æ°åã³ããã«ææããããâŠãæªãããæäœãçºèŠã倧éªå€§åŠ
ttps://www.asahi.com/articles/ASP3253TGP29PLBJ005.html
ã倧éªå€§åŠã®ç 究ã°ã«ãŒãã¯ãæ°åã³ãããŠã€ã«ã¹ã«å¯Ÿããå
ç«åå¿ã§äœå
ã«ã§ãããæäœãã®äžã«ããŠã€ã«ã¹ã«ææãããããªãåããæã€æäœãããããšãçºèŠãããæäœã¯éåžžãç
æ°ã®åå ãšãªããŠã€ã«ã¹ãæé€ããåããæã€ããããã°ãæªããããæäœãã ãšããã
ãã°ã«ãŒãã¯ãæ°åã³ããã«ææãããšã§ããæäœã人工çã«çŽ70çš®é¡ã€ãã£ãããããã®æäœãå ããŠãæ°åã³ãããŠã€ã«ã¹ããããã®çŽ°èã«äŸµå
¥ããéã«äœ¿ããã¹ãã€ã¯ããšåŒã°ããçªèµ·ãšã现èã®è¡šé¢ããã±ã質ã®çµåã®åŒ·ããå€ãããã©ãããå®éšããã
ãå®éšã®çµæãã¹ãã€ã¯ãšè¡šé¢ããã±ã質ã®çµåã匷ããæ°åã³ãããŠã€ã«ã¹ã®ææåãé«ããæäœãããããšãããã£ãããã®æäœããããšãã¹ãã€ã¯ã®æ§é ãå€ãã£ãŠçµåã匷ããææãããããªãå¯èœæ§ã瀺ãããã
[å¿åãã]
?
Good!
?
Bad
ãã³ãããåŸéºçã«å€ããã¬ã€ã³ãã©ã°ã®åå 解æã®æããããçºèŠãç±³ãžã§ã³ãºã»ãããã³ã¹å€§åŠç ç©¶å ±å æ¯çŽ°è¡ç®¡ã«å·šæ žç
ã³ããåŸéºçã®ããã¬ã€ã³ãã©ã°ããåå 解æã«ææãã
æ°åã³ãããŠã€ã«ã¹ææçïŒCOVID-19ïŒãããããããŸããŸãªçç¶ã®äžã«ã¯åå ã®è§£æãé²ãã§ããªããã®ãæ°å€ãããããã¬ã€ã³ãã©ã°ããã®äžã€ã ã
ãã¬ã€ã³ãã©ã°ãšã¯ãé ã«ã¢ã€ãããã£ããããªããŒãããããç¶æ
ã«ãªãçç¶ã®ããšãéçæ£è
ã«èµ·ããå¯èœæ§ããããCOVID-19ããã®å埩åŸãé·æã«ããã£ãŠåŸéºçãšããŠæ®ãå Žåãããã
ããããäžãç±³ãžã§ã³ãºã»ãããã³ã¹å€§åŠã®David Nauenæ°ãã¯ãCOVID-19æ»äº¡æ£è
ã®è³å
ã«æ¥µããŠç¹æ®ãªçŽ°èã®å¡ãçºèŠããããããã¬ã€ã³ãã©ã°ãç¥çµåŠçã«èª¬æããããã®ææããã«ãªãå¯èœæ§ã®ããããšãããJAMA Neurologyãã«2æ12æ¥å ±åããã
Nauenæ°ãã¯ä»åãCOVID-19ã«çœ¹æ£ããŠæ»äº¡ãã15人ã®æ£è
ã®åæ€ã§åŸãããè³çµç¹ãåæããããŸããæ°åã³ãããŠã€ã«ã¹ã«ææããŠããªãããè³ã«äœé
žçŽ èè¡æ§ã®å€æ§ãçããŠãã2人ã®æ£è
ã®è³çµç¹ã«ã€ããŠã調ã¹ãã
ãã®çµæãé©ãã¹ãããšã«ãCOVID-19眹æ£æ£è
ã®è³ã«ã¯ãççããªã³ãçã®æµžæœ€ãšãã£ãè³ã®ãŠã€ã«ã¹ææã®å
žåçãªå
åããã£ããèªããããªãã£ãã
ãšããããçŽ3åã®1ïŒ33ïŒ
ïŒã®æ£è
ã®è³ã®æ¯çŽ°è¡ç®¡ã«ãå·šæ žçãšåŒã°ãã现èãååšããããšãæããã«ãªã£ããããã«å¯ŸããŠãéæææ£è
ã®è³çµç¹ã«ã¯ãå·šæ žçã¯ç¢ºèªãããªãã£ãã
Nauenæ°ã¯ããå·šæ žçã¯éåžžãèµ€è¡çãªã©ã®è¡çãäœã骚é«ã«ååšãããè³ã®æ¯çŽ°è¡ç®¡ã¯è³å
šäœã«é
žçŽ ãéã¶åŸ®çŽ°ãªç®¡ã®ãããªãã®ãªã®ã§ãããã«å·šæ žçãèªãããšããã®ã¯ãéåžžã§ã¯ããåŸãªããããšããŠèšããªããèªå®
ã®çŽ°ãé
管ã«ãããããŒã«ãè©°ãŸã£ãŠããã®ãèŠã€ãããããªãã®ã ããšè©±ãã
ã§ã¯ãè³å
ã®å·šæ žçãCOVID-19æ£è
ã«ãã¬ã€ã³ãã©ã°ããããããŠããã®ã ãããïŒããã®ç¹ã«ã€ããŠNauenæ°ã¯ããå æé¢ä¿ã蚌æããã«ã¯è³ã£ãŠããªãããšåŒ·èª¿ããŠããã
[å¿åãã]
?
Good!
?
Bad
ãã®äžã§ããè³ã®æ¯çŽ°è¡ç®¡ã«å·šæ žçãçºèŠããã®ã¯ç¬¬äžæ©ã ã次ã¯ããªãè³ã«å·šæ žçãååšããŠããã®ããã©ã®ãããªäŒéçµè·¯ã§å·šæ žçãè³ã«éãããã®ããæããã«ããå¿
èŠãããããŸããå·šæ žçã®ååšãè³åäžãªã¹ã¯ãé«ããã®ãåŠããªã©ã®åé¡ã«ã€ããŠãæ€èšããå¿
èŠãããããšè©±ããŠããã
ãªããä»åNauenæ°ãã調ã¹ãæ£è
ã®äžã«ãè³åäžãçºçãã人ã¯ããªãã£ãããããããæ¯çŽ°è¡ç®¡ã®è€éãªãããã¯ãŒã¯ã¯ç¶¿å¯ã«èª¿ç¯ãããŠãããäžäžãé®æãããå Žåãè¡å§ãäžæããŠãè³åäžãªã¹ã¯ãé«ããå¯èœæ§ã¯ããããšåæ°ã¯ææããã
äžæ¹ãç±³ã±ã³ã¿ãããŒå€§åŠç¥çµåŠéšã®Larry Goldsteinæ°ã¯ãããã¬ã€ã³ãã©ã°ã¯ç¢ºç«ãããçŸæ£ã§ã¯ãªãããããå®çŸ©ãã蚺æåºæºããªãããšææã
ãŸããããã¬ã€ã³ãã©ã°ã¯COVID-19ã ãã§ãªããããŸããŸãªççæ§çŸæ£ãç¥çµå€æ§çŸæ£ãããååŠçæ³ã§äœ¿ãããè¬å€ã®äœ¿çšãªã©ã«ãé¢é£ããŠçããããšèª¬æããŠããã
Goldsteinæ°ã¯ãCOVID-19æ£è
ã®ãã¬ã€ã³ãã©ã°ãå·šæ žçã®ååšã§èª¬æã§ãããã©ããã«ã€ããŠãããã®å¯èœæ§ã¯ããããšã®èŠæ¹ã瀺ããŠããã
ãããããççãè¡æ¶²äžã®é
žçŽ ã®éã®æžå°ãè³åäžãè¡æµã®äœäžãªã©ãå·šæ žç以å€ã«ãããŸããŸãªèŠå ãèããããããšã話ããŠãããïŒHealthDay News 2021幎2æ17æ¥ïŒ
Copyright c 2021 HealthDay. All rights reserved.
ïŒåèæ
å ±ïŒ
Abstract/Full Text
ttps://jamanetwork.com/journals/jamaneurology/fullarticle/2776455?resultClick=1
é¢é£
æè倱ãååãèšæ¶ãããŸããæ°åã³ãããè³ãŸã§äŸµå
¥ã
ttps://www.asahi.com/articles/ASNCC5R1PNBXULBJ01B.html
[å¿åãã]
?
Good!
?
Bad
ãåœå
ã錻ã¹ãã¬ãŒã飲ãã¿ã€ããé䜿ããªãã¯ã¯ãã³ãéçºé²ã
欧米ã«ç¶ããåœå
ã§ãæ¥çš®ãå§ãŸã£ãæ°åã³ãããŠã€ã«ã¹ã®ã¯ã¯ãã³ã泚å°éãè
ã«æ·±ãåºããŠçèã«æã€ããçã¿ã«æµææãèŠãã人ãå€ããéã䜿ããªãã¿ã€ãã®ã¯ã¯ãã³ã®éçºãé²ãã§ããã
ãäžçä¿å¥æ©é¢ïŒWHOïŒã«ãããšã2æ23æ¥çŸåšã§ãäžçã§çŽ250çš®é¡ã®æ°åã³ããã¯ã¯ãã³ã®éçºãé²ããããŠããããã®ãã¡çŽ70çš®é¡ã人ã«æäžããèšåºè©Šéšãå§ãŸã£ãŠããã
ãåé倧åŠãªã©ã®ç 究ããŒã ãå®çšåãããããŠããã®ã¯ã錻ã«ã¹ãã¬ãŒããã¿ã€ãã®ãçµéŒ»ã¯ã¯ãã³ãã ãåœç«ææçç 究æãªã©ããåæ§ã®ã¿ã€ãã®ã¯ã¯ãã³ç 究ãé²ããŠããã
ãåé倧åŠã®çå±±å圊ææïŒãŠã€ã«ã¹ææå¶åŸ¡åŠïŒã¯ãã¯ã¯ãã³ã®æ³šå°éãå«ã ãšãã人ã¯å€ããã·ã¥ããšéŒ»ã«å¹ããããã ãã§å
ç«ãã€ãã°ãã¿ããªãè² æ
ãæããããšãªãæ¥çš®ã§ããããšè©±ãã
ããããŸã§çµéŒ»ã¯ã¯ãã³ã¯ãã€ã³ãã«ãšã³ã¶ã§ãéçºãé²ã¿ãç±³åœã§ã¯æ¿èªãããŠãããã®ãããããŠã€ã«ã¹ã¯éŒ»ãã®ã©ã®ç²èã«ãšãã€ããŠææãåŒãèµ·ããããçµéŒ»ã¯ã¯ãã³ã¯éŒ»ãã®ã©ã®å
ç«ãçŽæ¥æŽ»æ§åãããææãé²ãå¹æããããšãããŠããã
ïŒã€ã¥ãã¯äŒå¡èšäºäŒå¡èšäºã§ã
ttps://www.asahi.com/articles/ASP323FL0P2JPLBJ009.html
錻ã«ã¹ãã¬ãŒããã¿ã€ãã®ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®æ¥çš®ã®æ§åãæ°åã³ãããŠã€ã«ã¹ã§ãåæ§ã®ã¿ã€ãã®ç 究ãé²ã
ttps://www.asahicom.jp/articles/images/AS20210302000924_comm.jpg
[å¿åãã]
?
Good!
?
Bad
ãã¯ã¯ãã³ãå®æ²»åŸ³æŽ²äŒç
é¢ãèæ¡ãããã€ã³ã¹ãªã³æ³šå°åšã§7ååæ¡åã ååŽçžãèªãã
å®æ²»åŸ³æŽ²äŒç
é¢ã¯ã€ã³ã¹ãªã³çšã®æ³šå°åšã䜿ãã°7åæ¡åã§ãããšãããããã¯ç®äžæ³šå°çšã§ããã¡ã€ã¶ãŒè£œã®ã¯ã¯ãã³ã¯æ¬æ¥ãçèå
ãžã®æ³šå°ãå¿
èŠã ãç°ææ°ã¯ãç®äžæ³šå°çšã§éãçããããèèªãå°ãªãçèãŸã§éãå±ã人ã§ãªããã°äœ¿ããªãããšãããããšã³ãŒæ€æ»ã§èª¿ã¹ãŠçèãŸã§å±ãã®ã§ããã°ãå»çæ©é¢ã§ãã£ãŠãããããšã¯åŠå®ããªãããšããã
æ²³é倪éèŠå¶æ¹é©çžã¯9æ¥ã®é£è°åŸã®èšè
äŒèŠã§ãã倧ãã«ãã£ãŠã»ãããã¢ã€ãã¢ãã©ãã©ãåºããŠããããæè»æ§ãæã£ãŠããéåžžã«è¯ãäŸã ããšæè¿ãããæ²³éæ°ã¯6åæ¥çš®ã§ãã泚å°åšã®èª¿éèšç»ã«å€æŽã¯ãªãèãã瀺ããã7åæãŠã泚å°åšã®ç¢ºä¿ã«ã€ããŠã¯ãäœå°åãããã°èª¿éãèãåŸãããšææããã
ttps://www.nikkei.com/article/DGXZQODF090YH0Z00C21A3000000/
[å¿åãã]
?
Good!
?
Bad
ãéå ±ãçè·åž«ãã¹ãã©ã€ãã倧éªã®è€æ°ã®ç
é¢
çè·åž«ããã¹ãã©ã€ããã³ããäžãçžæ¬¡ãéè·ã«å±æ©æ
å±±äžç±çŠ
2021/3/9 9:15
ã倧éªåºé«æ§»åžã®è€æ°ã®æ°éå»çæ©é¢ãªã©ã§8æ¥ãé«æ§»å»ççŠç¥åŽåçµåïŒçµåå¡çŽ360人ïŒã«æå±ããè·å¡ãåŸ
éæ¹åãæ±ããŠã¹ãã©ã€ãã決è¡ãããæ°åã³ãããŠã€ã«ã¹ã®æææ¡å€§ã§å€åç°å¢ãå³ãããªã£ãŠãããåŽçµã¯ãå°åå»çãå®ãããã«å»çåŸäºè
ãæ¯ããå¿
èŠãããããšèšŽããã
ADVERTISEMENT
ãã¹ãã¯å¯ç°çºç
é¢ãªã©3ã«æã§ãã£ããçè·åž«ãäºåè·å¡ãçŽ20人ã¯å§æ¥ã®åå8æåããçŽ1æéã®æéã¹ããããåŽçµåœ¹å¡ã7人ã¯åæ¥å€ãŸã§ã¹ããç¶ãããå¯ç°çºç
é¢ã«ãããšã蚺çã«æ¯éã¯ãªãã£ãã
ãåç
é¢ã¯69åºãåŽçµã«ãããšãçµå¶é£ã®ããã2019幎å€ïœ20幎å¬ã®è³äžã¯4åé£ç¶ã§0ã»8ã«æåã«ãšã©ãããç
é¢ã§ã¯æšå¹Ž12æ以éã§çè·åž«6人ãšä»è·è·å¡1人ãéè·ã»éè·äºå®ã ãšããã
ãåŽçµã¯ãã³ããçŠã§åŽåç°å¢ãæªåããŠããã®ã«åŸ
éæ¹åããªããã°ããã«éè·è
ãå¢ããæãããããšããŠã¹ãã«èžã¿åã£ãã
ãç
é¢äºåè·ã§åŽçµã®æå±±è£åå·è¡å§å¡é·ã¯8æ¥ããã³ããçŠã§ç
é¢ã¯2åå以äžã®å
¬çèè³ãåããŠããããªãçŸå Žã®åªåã«å°ãã§ãå ±ãããšããªãã®ããéè·ãæ¢ãŸããªããã°ç
é¢ã厩å£ããŠããŸãããšèšŽããã
ãå¯ç°çºç
é¢ã®éå¶æ³äººã®æ
åœè
ã¯åæã«ãå»çæ©åšã®ä¿®ç¹ãéè·éç©ã¿ç«ãŠãªã©ã«å€é¡ã®è²»çšãããããæ¥çžŸãå埩ããã°æ¯çµŠé¡ãäžããŠããããããšè©±ãããïŒå±±äžç±çŠïŒ
ttps://www.asahi.com/articles/ASP3874WRP36PPTB003.html
[å¿åãã]
?
Good!
?
Bad
ãã³ãããç±³CDCãæ¹éå€æŽãã¯ã¯ãã³æ¥çš®å®äºããã°ãã¹ã¯ç¡ãã®äº€æµå¯
ç±³çŸç
察çã»ã³ã¿ãŒïŒCDCïŒã¯ïŒæ¥ãæ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³æ¥çš®åŸã®å¯Ÿçã«é¢ããæ°ããªæ¹éã瀺ãããããã«ãããšãå®å
šã«æ¥çš®ãæžãŸãã人å士ã§ããã°ã亀æµã«ããææãªã¹ã¯ã¯ãªãããšããããã¹ã¯ççšãããã³ãœãŒã·ã£ã«ãã£ã¹ã¿ã³ã¹ç¶æã®å¿
èŠã¯ãªãã
CDCã¯æ°ããªæ¹éã«ã€ããŠèšåããäžã§ãã¯ã¯ãã³æ¥çš®ãå®äºããŠãã2é±éåŸã«ãã¹ã¯ççšãããã³ãœãŒã·ã£ã«ãã£ã¹ã¿ã³ã¹ç¶æã®çŸ©åã解é€ããŠããã
ç¶ãã¯ãœãŒã¹å
ã«ãŠ
ttps://jp.sputniknews.com/covid-19/202103098212197/
[å¿åãã]
?
Good!
?
Bad
ãCDCãInterim Public Health Recommendations for Fully Vaccinated People
For the purposes of this guidance, people are considered fully vaccinated for COVID-19 â¥2 weeks after they have received the second dose in a 2-dose series (Pfizer-BioNTech or Moderna), or â¥2 weeks after they have received a single-dose vaccine (Johnson and Johnson [J&J]/Janssen ).â
The following recommendations apply to non-healthcare settings.
Fully vaccinated people can:
ã»Visit with other fully vaccinated people indoors without wearing masks or physical distancing
ã»Visit with unvaccinated people from a single household who are at low risk for severe COVID-19 disease ãããindoors without wearing masks or physical distancing
ã»Refrain from quarantine and testing following a known exposure if asymptomatic
ttps://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated-guidance.html
[å¿åãã]
?
Good!
?
Bad
ã³ããåŸéºçããåŠæ æãçã¿æãç¥çµå
ç«ç³»çŸæ£MEã»CFS
æ¯æ¥æ°è
æ°åã³ãããŠã€ã«ã¹ã®ææè
ãã®éã§ãæ¥åžžç掻ãå°é£ã«ãªãã»ã©åŒ·ãåŠæ ïŒããããïŒæãç¶ããªã©åŸéºçãšã¿ãããçç¶ã«æ©ãã±ãŒã¹ãçžæ¬¡ãã§ãããç¥çµå
ç«ç³»çŸæ£ãççæ§è³èé«ïŒããããïŒçïŒMEïŒã»æ
¢æ§ç²åŽçå矀ïŒCFSïŒãã匷ãçããããšãããåœå
å€ã®å°é家ã¯ãæ°åã³ãããåŒãéã«ãªãå¯èœæ§ã¯ååããããšèŠéã鳎ãããæ²»çæ³ããŸã ãªããæ©æ確ç«ãåŸ
ããããã®ç
æ°ãšæ°åã³ãããšã®é¢ä¿ãšã¯ã
ãçžæš¡ååžã®ããŒãã®å¥³æ§ïŒ48ïŒã¯æšå¹Ž3æã埮ç±ãé çãæ¯åããåŠæ æãªã©ãçºçãããæ°åã³ããã®ææãçãããããã€ãå»ãå蚺ããããç±ã37ã»5床ãè¶
ããªãã£ãããPCRæ€æ»ã¯åããããªãã£ãã颚éªè¬ãåŠæ¹ããããç
ç¶ã¯æªåããäžæ¹ã§ã箞ãæã€ã ãã§æã«æ¿çãèµ°ããç
é¢ã«è¡ã£ãç¿æ¥ã¯ç²åŽæã§èµ·ãäžããããšãã§ããªãã£ãã女æ§ã¯ããŒããäŒè·ãå幎ãããŠè¡æ¶²æ€æ»ãã¬ã³ãã²ã³æ€æ»ãªã©ã§å
šèº«ã調ã¹ãŠãåå ã¯èŠã€ãããªãã£ããã12æã«æ°åã³ããã®ææçãã匷ããšèšºæããã1æã«ã¯ãMEã»CFSããšèšºæãããã
[å¿åãã]
?
Good!
?
Bad
ãç 究ã ã³ããæææ¡å€§ã®åã« ã飲ã¿äŒããã€ãŒãå¢ããã第3æ³¢çŽåã«ããŒã¯ã»ã»ã»æ±éŠå€§åŠ
ã飲ã¿äŒããªã©ã®èšèãå«ãSNSäžã§ã®çºä¿¡ããæ°åã³ãããŠã€ã«ã¹ã®ææè
æ°ã®å¢å ã«å
è¡ããŠå¢ããå¯èœæ§ããããšããåæã
æ±éŠå€§åŠã®ç 究ã°ã«ãŒãããŸãšããŸãããã°ã«ãŒãã¯ãæææ¡å€§ã®å
ããéããã«ææ¡ã§ããææšãšããŠå©çšã§ããå¯èœæ§ããããšããŠã
ä»åŸããã«åæãé²ããŠããããšã«ããŠããŸãã
æ±éŠå€§åŠã®å
è€ç¯€åœŠææã®ç 究ã°ã«ãŒãã¯ããã€ãã¿ãŒã§ã€ã¶ããããç¹å®ã®ããŒã¯ãŒãã«çç®ããããšã§
æ°åã³ãããŠã€ã«ã¹ã®ææã®åºãããäºæž¬ã§ããªãããå»å¹Ž9æ以éã®ãã€ãŒããåæããŸããã
ãã®çµæãææã®ç¬¬3æ³¢ãå§ãŸã£ããšã¿ãããå»å¹Ž11æã«å
¥ãåã«ããä»æ¥ãã飲ã¿äŒãã®2ã€ã®åèªãåæã«å«ããã€ãŒãã®æ°ã®ããŒã¯ããã£ããšããããšã§ãã
ãä»æ¥ããã«ã©ãªã±ãã§ã¯ããããããŒã¯ã¯ã¿ãããŸããã§ããã
ããã§ã°ã«ãŒãããä»æ¥ãã飲ã¿äŒããå«ããã€ãŒãã®1é±éã®åèšãããã®åé±ã®åèšã§å²ã£ãå€ããæ°ã®ç·©ã¿ææ°ããšåä»ããŠå€åã調ã¹ããšããã
å»å¹Ž10æã®ç¬¬4é±ãããã®ææ°ãé«ãç¶æ
ãç¶ããå®éã®ææè
æ°ã¯ãã®2é±éåŸã®11æäžæ¬ã«å¢å åŸåã匷ãŸã£ãŠãããšããããšã§ãã
ãã®ããã°ã«ãŒãã¯ããã®ææ°ã第3æ³¢ã®å
ãã瀺ããŠããå¯èœæ§ããããšããŠã
ä»åŸå€§ããªæææ¡å€§ãäºåã«äºæž¬ã§ããææšãšããŠå©çšã§ããã®ã§ã¯ãªãããšããŠããŸãã
å
è€ææã¯ãææšãšããŠã®ç²ŸåºŠã¯ããã«æ€èšŒãéããªããã°ãªããªãããææã®åºããããã¡æ©ãå¯ç¥ããŠäººã
ã«æ³šæãåŒã³ãããæ段ãšããŠã¯æå¹ã ãšèããŠããã
ä»æã«å
¥ã£ãŠãããã€ãŒãæ°ãããå¢å ããåŸåã«ãããææãåã³æ¡å€§ããªãããä»åŸã®ææç¶æ³ãšãç
§ããåãããªããããã«åæãé²ãããããšè©±ããŠããŸãã
ttps://www3.nhk.or.jp/news/html/20210312/k10012911721000.html
[å¿åãã]
?
Good!
?
Bad
ãã€ãã«ã¡ã¯ãã³çºèŠè
ã»å€§æå士ã蚎ãã ãç¹äŸæ¿èªãã¹ããåœå
ã§ãæçšæ£è
ã¯ãã£ãšããéã«æ²»ã£ãã
ã¯ã¯ãã³ã®åœå
ã§ã®æ¥çš®ãéå§ããããåæã«æ²»çè¬ãéèŠã ããããã®çé ãããŒãã«è³åè³ã®å€§ææºå士ãçºèŠãããã€ãã«ã¡ã¯ãã³ãã¯
äžçåå°ããç®èŠãŸããå¹æãå ±åãããŠããã倧æå士æ¬äººãç¹äŸæ¿èªãã¹ãããšèšŽããã
ãæ²»éšã«ã¯æéãããããŸãããæµ·å€ã®ããŒã¿ãè±å¯ãªã®ã ãããæ¥æ¬ã§æ²»éšãããªããŠãããã®ã§ã¯ãªããã
å°é家ãæ°åãåºããŠããããã«å¹ããŠãããšçºè¡šããŠããã®ã ãããããããã£ãŠç¹äŸæ¿èªããŠã»ããã§ãã
ããã§äœ¿ããªããã°ããªãã®ããã®ç¹äŸæ¿èªã®å¶åºŠãªã®ã§ãããããæ²»éšãåŸ
ã£ãŠãããã亡ããªã£ãŠããŸã人ãããã®ã§ãã
ãã蚎ããã®ã¯ã»ããªãã¬å€§æå士ã§ãã€ãã«ã¡ã¯ãã³ã«ã€ããŠèª¬æããã
ãå
ã«ãªããšããŒã¡ã¯ãã³ãšããç©è³ªã¯ãäŒè±ã®å·å¥ã®ãŽã«ãå Žè¿ãã§æ¡åããåãç 究宀ã«æã¡åž°ãã
ããããåé¢ãã埮çç©ããçºèŠãããŸãããäžçäžã§ãšããŒã¡ã¯ãã³çšã«å¹é€ããŠãã埮çç©ã¯ãå
ã蟿ãã°ãã®åãããšããã®ã§ãã
ç§ãé¢ãã£ãã®ã¯ç·è«ãªã©ã«å¹ããšãããŸã§ã§ããã®åŸãæµ·å€ã®å€ãã®ç 究è
ããŠã€ã«ã¹ãããã«å¹ããšçºè¡šããŠããŸãã
ç·è«ã®è¬ããªããŠã€ã«ã¹ã«ããšèãããŸãããäžæè°ã§ã¯ãããŸãããã€ãã«ã¡ã¯ãã³ã¯ãã¯ãã©ã€ãç³»æçç©è³ªã«åé¡ããã
ãã®ç³»çµ±ã®è¬ã¯ç¬¬2ã第3ã®äœçšããã€ããšãå€ãã®ã§ãã
颚éªãªã©ã«åŠæ¹ããããšãªã¹ããã€ã·ã³ããã¯ãã©ã€ãç³»æçç©è³ªã§ãããã¢ããªã³ãšããæ¶åãå©ãããã«ã¢ã³ãšåãäœçšããã£ããã
æççäœçšããã£ãŠãããããªã©ã«å¹ããããããŸãããŸãé節ãªå¯äœçšã®å ±åããªããã¢ããªã«ã§ãã®è¬ãé
ã£ãŠããã®ãå»åž«ãçè·åž«ã§ã¯ãªãã
äž»ã«ãã©ã³ãã£ã¢ãªã®ããå±éºæ§ããªãããã§ããäœé50ïœ60ããã®äººã¯3ããªã°ã©ã ã®é å€ã3ïœ4é 飲ãã°ãããããã ãå°éã§å¹ãã®ããããããšã§ãã
[å¿åãã]
?
Good!
?
Bad
æ°åã³ããã«å¯Ÿããã€ãã«ã¡ã¯ãã³ã®äœçšã ãã
ããŠã€ã«ã¹ã®å¢æ®ãæããã ãã§ãªããäœã«åãããããŠã€ã«ã¹ã«ææããéã®ççãæããäœçšãšã
å
ç«æ©æ§ã§ãŠã€ã«ã¹ããã£ã€ããæ©èœã掻æ§åããå¹æãããããšãªã©ãçºè¡šãããŠããŸãã
ãŠã¿å€§åŠã®è«æã¯æ
å ±æäŸäŒç€Ÿã®ãã¹ã§åãäžãããããã®ããã§å¹æãçåèŠããåãããããŸããã
ãããçŸå®ã«ã¯ãã€ãã«ã¡ã¯ãã³ã¯æ°åã³ããã«å¹ããªãããšããè«æãèŠåœãããªããšããã»ã©ã§ãã
ãã«ãŒã§ã¯ãã€ãã«ã¡ã¯ãã³ã飲ãŸããå·ã®æ»äº¡çãã©ãã©ãäžãã£ãäžæ¹ã飲ãŸããªãã£ããªãå·ã§ã¯äžãããã
倧統é ã亀æ¿ããŠé£²ãŸããã®ãã»ãŒããããã飲ãã§ããå·ã§ãæ»äº¡çãäžãã£ãŠããããšããããšãå ±åãããŠããŸãã
ttps://www.dailyshincho.jp/article/2021/03141057/?all=1&page=1
[å¿åãã]
?
Good!
?
Bad
è±ç²éãæ°åã³ããææãªã¹ã¯ãé«ãããšãã説
ãã¥ã³ãã³å·¥ç§å€§åŠãªã©ãçºè¡šããç 究ã«ããã°ãè±ç²ãžã®æé²ãšCOVID-19ãšã®ææçã«çžé¢é¢ä¿ãããããã ããã®ç 究ã¯2019幎9æ11æ¥ã«çºè¡šãããè±ç²ãæãŠã€ã«ã¹å
ç«ã劚ããããšã«ã€ãªããããæ€èšŒããè«æãå
ãšãªã£ãŠãããããŠã¹ã§ã®å®éšã§ã¯è±ç²æ¿åºŠãæãŠã€ã«ã¹éºäŒåã®çºçŸãäžããããšã«ã€ãªãããèºã®ãŠã€ã«ã¹å䟡ãäžæãããšããçžé¢æ§ããã£ãããã ãããã§ãã¥ã³ãã³å·¥ç§å€§åŠãç±³ã³ãã³ãã¢å€§åŠãã®ç 究ããŒã ã¯ã2020幎1æ1æ¥ãã4æ8æ¥ãŸã§ã®ããŒã¿ãããCOVID-19ãžã®ææçãšè±ç²æ¿åºŠã®é¢é£ã調ã¹ãŠã¿ããšã®ããšïŒãã¥ãŒãºãŠã£ãŒã¯ïŒã
maia æ°ãã
è±ç²é£æ£éãå¢ãããšæ°åã³ãããžã®ææãªã¹ã¯ãé«ãŸãããšãããã£ã
ãã¥ã³ãã³å·¥ç§å€§åŠãªã©ã®ç 究ã«ãããšãæ°åã³ããææçã®å€åã®44ïŒ
ãè±ç²ãžã®æé²ãšé¢é£ããããè±ç²æ¿åºŠã®äžæãã4æ¥åŸã«ææçãäžæããåŸåãããããšãããã£ã...
ïŒäžç¥ïŒ2020幎1æ1æ¥ãã4æ8æ¥ãŸã§ã®ããŒã¿ãçšããŠ
æšå¹Žãæ¥å
ã«å¢å ãããããã§å¬ã®æ°æž©äœäžå±é¢ãšæ¥å
ã®ããŒã¯ã説æåºæ¥ããšä»®å®ãããšïŒ44ïŒ
ãšããäºãªã®ã§100ïŒ
ã§ã¯ãªããããšãããæ°åã³ããã®æµè¡ã¯ç€ŸäŒçèŠå ãªã©è€åçã ããïŒãåŸã¯å€ã®æ°æž©äžææã®ããŒã¯ã®èª¬æãåºæ¥ããšè¯ãããŸãæ°åã³ããã®å¹Žéãµã€ã¯ã«ã¯æŠã3å³°æ§ãšããäºã«ãªãã®ã ãããã
ttps://srad.jp/story/21/03/15/1944234/
[å¿åãã]
?
Good!
?
Bad
ãPCRæ€æ»ã æ°Žã«ãéœæ§ãåå¿ïŒãã³ããæ€æ»è¬ãæ§èœã«ã°ãã€ã
åœç«å»è¬åé£åè¡çç 究æïŒåœç«è¡ç ïŒããPCRæ€æ»ãªã©ã®æ°åã³ãããŠã€ã«ã¹æ€æ»è¬ãæ¯èŒãããšããã
ãŠã€ã«ã¹ã®éºäŒç©è³ªãå°ãªãå Žåã¯ãæ€åºã§ããæ§èœã«ã°ãã€ããããããšãããã£ãã
äžã«ã¯éºäŒç©è³ªãå«ãŸããªãæ°Žã§ããéœæ§ããšåºããã補åãèŠã€ãã£ãã
æ€æ»è¬ã¯ã³ããã®æµè¡ã«å¯Ÿå¿ããããæ¥ãã§éçºãããããã®ããåœç«è¡ç ã¯ä¿éºé©çšãããŠåºã䜿ãããŠãã補åã§ãã
æ§èœã®è©äŸ¡ã«äœ¿ãããæ€äœãåãã§ã¯ãªããšèããæ¯èŒããããšã«ããã
2020幎3ïœ5æã«äœ¿çšèš±å¯ãåºã9補åã調ã¹ãã
æ°åã³ãããŠã€ã«ã¹ã®éºäŒç©è³ªã®æ¿åºŠãå€ãã6çš®é¡ã®æ¶²ããããã12åè©Šããéœæ§ã«ãªããã©ããã調ã¹ãã
ãããšãåœç«ææçç 究æïŒææç ïŒã®æ€åºããã¥ã¢ã«ã«èšãããæ¿åºŠã§ã¯ãå
šãŠã®æ€æ»è¬ã§12åãšãéœæ§ãšå€å®ã§ããã
ããããæ¿åºŠãäœãå Žåãæ¯åæ€åºã§ããæ€æ»è¬ããå
šãæ€åºã§ããªãæ€æ»è¬ããã£ãã
çµæã¯åœç«è¡ç ã®ãµã€ãã§å
¬éïŒ ttps://www.nihs.go.jp/mtgt/covid-19info.htmlå¥ãŠã€ã³ããŠã§éããŸãïŒããã
ããäŒæ¥ã®æ€æ»è¬ã¯ãéºäŒç©è³ªãå«ãŸããªãæ°Žã§ã12åäž4åããéœæ§ããšå€å®ããããåœéœæ§ããèµ·ããããã£ãã
å瀟ãæ€èšŒãããšãããæ€æ»è¬ãå
¥ããããã¬ãŒãããšãæ€æ»è£
眮ã®çµã¿åããã«ãã£ãŠãåœéœæ§ã«ãªããããããšãããã£ãã
å¥ã®ç¹å®ã®çµã¿åããã§ã¯åœéœæ§ãäžäŸãçããªãããšãããã£ãã
ttps://www.asahi.com/articles/ASP3K52T0P33PLBJ002.html
[å¿åãã]
?
Good!
?
Bad
ãã³ãã第ïŒæ³¢ãæ±äº¬éœå»åž«äŒãåå®ã«èšŽããç¹å¹è¬ãã€ãã«ã¡ã¯ãã³ã䜿çšããå€ç°ãŠã€ã«ã¹ã«ãæå¹ã
æ±äº¬éœå»åž«äŒãåå®ã«èšŽããç¹å¹è¬ãã€ãã«ã¡ã¯ãã³ã䜿çšããå€ç°ãŠã€ã«ã¹ã«ãæå¹ã
é±åæ°æœ® 2021幎3æ25æ¥å·æ²èŒ
ttps://www.dailyshincho.jp/article/2021/03201059/
â æ±äº¬éœå»åž«äŒé·ãã³ããã®è¬ãšããŠãããªãããå ±åãã
ãæ¿åºã¯3æ18æ¥å€ãæ°åã³ãããŠã€ã«ã¹å¯ŸçãšããŠæ±äº¬ãåŒçãåèãç¥å¥å·ã®éŠéœå1éœ3çã«çºä»€äžã®ç·æ¥äºæ
宣èšã«ã€ããŠã21æ¥ã§å
šé¢è§£é€ããããšã決å®ããããããªäžã第4æ³¢ã«åããŠæ±äº¬éœå»åž«äŒã䜿çšãæèšããŠããã®ããããŒãã«è³åè³ã®å€§ææºå士ã®çºèŠããéçºããããã€ãã«ã¡ã¯ãã³ãã§ããã
ãïŒïŒïŒ
ã第4æ³¢ã«åããŠã¯ã¯ãã³ãšãšãã«éèŠãªã®ããæ²»çè¬ã®æŽåã ãçŸåšã泚ç®ãããŠããè¬ã®ãªãã«ãã€ãã«ã¡ã¯ãã³ããããæ¬èªïŒãé±åæ°æœ®ãïŒã3æ11æ¥å·ã§åãäžããäž»æšã¯ãæ±äº¬éœå»åž«äŒã®å°ŸåŽæ²»å€«äŒé·ã3æ10æ¥ãã©ãžãªçªçµã§èªã£ãå
容ã端çã«ç€ºããŠããã®ã§ãäžéšãåŒçšãããã
ãããŒãã«è³ãåè³ããã倧ææºå
çãçºèŠãããåå£ã®åŸ®çç©ããåæããŠäœã£ããã®ã§ãããšããšã¯æå¯çè«è¬ã§ããã¢ããªã«ãåç±³ãªã©ã§ã¯ãªã³ã³ã»ã«ã«çãšããææçãããããããåå ã§å€±æãããŠããæ¹ããšãŠãå€ãã£ãã®ã§ããããã®ã€ãã«ã¡ã¯ãã³ãã§ããŠãããããã£ãæ¹ãã©ãã©ãæžããäœçŸäžäººãæãããŠããŸããïŒäžç¥ïŒå®ã¯ãã®è¬ã¯ã27ã«åœã§äžççã«æ²»éšãè¡ãããŠãããã³ããã®è¬ãšããŠãããªãããå ±åããããŸãã
â æ²»éšäžè¶³ããæ¿æ²»çå€æãã
ãæ¥æ¬ã§ãæ²»éšãè¡ãããŠãããããã®çµæãåŸ
ããã«ãç·æ¥äœ¿çšããèªããŠã»ãããšå°ŸåŽäŒé·ãå®ã¯æ±äº¬éœå»åž«äŒã¯3æ9æ¥ã®äŒèŠã§ããã第4æ³¢ãã«åããã€ãã«ã¡ã¯ãã³æäžãæ€èšãã¹ãã ãšæèšããŠãããè§ç°åŸ¹å¯äŒé·ã説æããã
[å¿åãã]
?
Good!
?
Bad
ãçŸç¶ããšããã³ã¹äžè¶³ãææãããã€ãã«ã¡ã¯ãã³èªå¯ã®åããå éããããããã®ããã«åé倧åŠã§è¡ãããŠããæ²»éšãåéãããžã§ã¯ããåŸæŒãããŸããæ²»éšã§ã¯ã€ãã«ã¡ã¯ãã³ãšãã©ã»ãïŒåœè¬ïŒã®ããŒã¿ã120äŸãã€æããå¿
èŠãããã®ã«ããŸã 40äŸã»ã©ããéãŸã£ãŠããŸãããå»åž«äŒããæ²»éšã«ååããŠãããæ¹ãéããã®ã«å°œåããŸãããã ãé 調ã«æ²»éšãé²ãã§ãååŽçã«ç³è«ãããŸã§ã«1幎ã¯ããã£ãŠããŸããçŸç¶ã§ã䜿ããŸãããä¿éºé©çšå€ã«ãªã£ãŠããŸãã®ã§ãç·æ¥ã§äœ¿çšã§ããç°å¢ãäœãããããã§ã«æµ·å€ã§ãå€ã䜿ããããŒã¿ãéãŸã£ãŠããã®ã§ãå»åž«ã®è£éã§äœ¿ã£ãŠãããããšããæ¿æ²»çå€æãããŠããã ãããåããããŠããŸãã3æã«ã¯èªæ°å
ã®æ°åã³ãã察çå»çç³»è°å¡å£æ¬éšã®å匷äŒã«ãåéã®å
çãšäžç·ã«ãéªéããã€ãã«ã¡ã¯ãã³ã®çŸç¶ãšèª²é¡ãè°è«ããŸããã
ãããäžã€ãäŸçµŠã®åé¡ã§ã
ãçŸç¶ãæ¥æ¬ã§ã¯ã€ãã«ã¡ã¯ãã³ã¯ãç¥ç¬ãªã©å¯çè«ã«å¯ŸããŠèªå¯ãããŠããã ãã§ããããåæã«è£œé ãããŠããã®ã§ãã³ããã«äœ¿ãã«ã¯çµ¶å¯Ÿæ°ã足ããŸãããã€ãã«ã¡ã¯ãã³ã®è£œé å
ã§ããç±³åœã®è£œè¬äŒç€Ÿã¡ã«ã¯ã®æ¥æ¬æ³äººMSDã«ããããããäºæ
ãäŒããæèŠäº€æãããŠããŸãã
â ãå€ç°ãŠã€ã«ã¹ã«ãæå¹ã
ãè°å¡å£æ¬éšé·ã®åšå²¡å代è°å£«ãè¿°æããã
ãç§ã©ããå»åž«äŒåæ§ãèªå®
çé€è
ããã£ãšããŠããã ãã®ç¶æ³ãå€ããããè§ç°å
çã«ãè¶ãããã ãããšããå»ç³»è°å¡å
šå¡ãâç§ãã¡ããããã°âãšããæããæ°ãã«ãããšæããŸããæ²»éšã®äººéãã«ãååããŸãããã ãã¡ã«ã¯ã¯å€§æå
çã®èšèãåããã°ãã€ãã«ã¡ã¯ãã³ãäžã«åºããããªãã®ã§ã¯ãªãããããŸã®ç€Ÿé·ã«ãªã£ãŠåå©äž»çŸ©ã«åŸãããšã®åãèããã倧æå
çãã¡ã«ã¯ãšçžãåããããããªãæ§åã§ããã
[å¿åãã]
?
Good!
?
Bad
ãæè¬ã®æ°æã¡ãéœäŒã®æåã·ã§ããå»çè
ã«ãã«ããã»äŒæŽ¥è¥æŸ
æ±äº¬ã®æåã·ã§ããå»çè
ã«ãã«ãã äŒæŽ¥è¥æŸ
ttp://www3.nhk.or.jp/lnews/fukushima/20210323/6050013904.html
â»NHKããŒã«ã«ãã¥ãŒã¹ã¯å
èšäºãæ¶ããã®ãæ©ãã®ã§åŸ¡æ³šæã
æ°åã³ãããŠã€ã«ã¹ã®æææ¡å€§ãç¶ãäžãå°åå»çã®æåç·ã§åã人ãå±ãŸãããšã
æ±äº¬ã®æåã·ã§ããããäŒæŽ¥ã®é£æããµãã ãã«äœ¿ã£ããã«ãããã€ãããäŒæŽ¥è¥æŸåžã®ç
é¢ã«å±ããŸããã
ããã¯ãæ±äº¬ã»åéå±±ã®ã¬ã¹ãã©ã³ã®æ柀ç±æµ©ã·ã§ããããå
šåœã®é
èµã§çãåºããè¡ãåãçµã¿ãšããŠ
å
æãå¯å±±çã§åããŠè¡ããïŒïŒæ¥ã¯ã第ïŒåŒŸãšããŠãäŒæŽ¥è¥æŸåžã®ãå®®æ³é
é ãã§è¡ããŸããã
ãã«ããã«äœ¿ãã³ã¡ã¯äŒæŽ¥ç£ã®ã³ã·ãã«ãªã§ãé
èµã®ä»èŸŒã¿æ°Žã䜿ã£ãŠçãããã
äŒæŽ¥å°é¶ãšããŒããªã©ãçèŸãçãããã®ãšãäŒæŽ¥å°æ¹ã§ä¿åé£ãšããŠèŠªããŸããŠããã
ã«ããã®çé²ç
®ãšå°å
ã§ãšããå±±èãããããã®ã®ãïŒçš®é¡ã®å
·ãçšæããŸããã
ãããŠãé
èµã®é¢ä¿è
ãªã©ãããïŒïŒäººããç
é¢ã«å±ããïŒïŒïŒåã®ãã«ãããã²ãšã€ã²ãšã€ãäžå¯§ã«æ¡ã£ãŠããŸããã
ãã®ããšãæ柀ã·ã§ããã¡ã¯ãäŒæŽ¥è¥æŸåžã®äŒæŽ¥äžå€®ç
é¢ã蚪ããæŠåžåä¹ç
é¢é·ãã«ãã«ãããææž¡ãã
ç
é¢ã®è·å¡ãã¡ã¯ãããããã«ã»ãã°ã£ãŠããŸããã
è·å¡ã®å¥³æ§ã¯ããã«ããã®å
·ã«ã«ããã¯åããŠã§ãããããšãŠãããããã£ãã§ãã
ååŸããä»äºãé 匵ãããã§ãããšè©±ããŠããŸããã
æ柀ã·ã§ãã¯ããã®åå°ãªãã§ã¯ã®é£æã䜿ããæãã蟌ããŠã€ãããŸããã
å»çåŸäºè
ã®çããã«å°ãã§ãæè¬ã®æ°æã¡ãäŒããã°ãããããã§ãããšè©±ããŠããŸããã
03/23 15:30
[å¿åãã]
?
Good!
?
Bad
ãæ®éã®é¢šéªã®ãŠã€ã«ã¹ããæ°åã³ãããŠã€ã«ã¹ãé§éããããšãå€æ
å¹é€ããã人ã®çŽ°èã«ãæ°åã³ãããŠã€ã«ã¹(SARS-CoV-2)ãšé¢šéªã®ä»£è¡šçãªåå ãŠã€ã«ã¹ãšããããã©ã€ããŠã€ã«ã¹ãåæã«ææãããå®éšã®çµæããã©ã€ããŠã€ã«ã¹ã®ååšãSARS-CoV-2ã®è€è£œãé»å®³ããããšããããšãå€æããŸããããŠã€ã«ã¹ãšãŠã€ã«ã¹ã®çžäºäœçšã«é¢ããæ°çºèŠã«ãããæ°åã³ãããŠã€ã«ã¹ææç(COVID-19)察çãããã«é²å±ãããšæåŸ
ãããŠããŸãã
Human rhinovirus infection blocks SARS-CoV-2 replication within the respiratory epithelium: implications for COVID-19 epidemiology | The Journal of Infectious Diseases | Oxford Academic
ttps://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiab147/6179975
University of Glasgow - University news - Infection with common cold might provide some protection against COVID
ttps://www.gla.ac.uk/news/headline_781603_en.html
ã©ã€ããŠã€ã«ã¹ã¯é¢šéªã®ä»£è¡šçãªåå ãŠã€ã«ã¹ã®1ã€ã§ã33床ãšãã枩床ã§ããå¢æ®ããªãããšãããäžæ°éã«ãã现èã«ããææããªããšããããŠããŸãããããŸã§ã®ç 究ã«ãããã©ã€ããŠã€ã«ã¹ãšä»ã®åŒåžåšç³»ãŠã€ã«ã¹ã®çžäºäœçšããææçã®éç床ãææã®åºããæ¹ã«åœ±é¿ãäžããããšãåãã£ãŠããŸããããSARS-CoV-2ãšã®çžäºäœçšã«ã€ããŠã¯äžæãªãŸãŸã§ããã
[å¿åãã]
?
Good!
?
Bad
ããã§ãã€ã®ãªã¹ã»ã°ã©ã¹ãŽãŒå€§åŠã®ãããã»ã ã«ã·ã¢ææãã®ç 究ããŒã ã¯ã人éã®åŒåžåšç³»ã®çŽ°èã«SARS-CoV-2ãšã©ã€ããŠã€ã«ã¹ãåæã«æ¥çš®ããŠå¹é€ããSARS-CoV-2ãå¢æ®ããæ§åã芳å¯ãããšããå®éšãè¡ããŸããããã®çµæãSARS-CoV-2ã¯æ¥æ¿ã«æžå°ãã48æéåŸã«ã¯å
šãæ€åºãããªããªããŸããããã®åŸåã¯ãå
ã«ã©ã€ããŠã€ã«ã¹ã«ææãããŠããããã®24æéåŸã«SARS-CoV-2ãæäžããå Žåã§ãåæ§ã§ãããããã«ãå
ã«SARS-CoV-2ã«ææãããŠããã24æéåŸã«ã©ã€ããŠã€ã«ã¹ãæäžããå Žåã§ããSARS-CoV-2ã¯ã©ã€ããŠã€ã«ã¹ãæäžãããçŽåŸã«æ¥æ¿ã«æžå°ããããã«æ¶æ»
ããŠããŸã£ããšã®ããšã§ãã
ãã®çµæã«ã€ããŠãã ã«ã·ã¢ææã¯ãä»åã®ç 究ã«ãããã©ã€ããŠã€ã«ã¹ã人éã®åŒåžåšã®çŽ°èã®èªç¶å
ç«åå¿ãèªçºããSARS-CoV-2ã®è€è£œãé»æ¢ããããšãæããã«ãªããŸãããã€ãŸãã軜ã颚éªãåŒãèµ·ãããŠã€ã«ã¹ã«ææããããšã«ãã£ãŠèµ·ããå
ç«åå¿ããSARS-CoV-2ã«å¯Ÿããäžæçãªé²åŸ¡ãšãªããSARS-CoV-2ã®ææãé»æ¢ãããCOVID-19ã®éçåãæå¶ãããããå¯èœæ§ããããšããããšã§ãããšè¿°ã¹ãŸããã
ã ã«ã·ã¢ææã¯ããã«ãã次ã®æ®µéã®å®éšã§ã¯ãä»å確èªããããŠã€ã«ã¹ãšãŠã€ã«ã¹ã®çžäºäœçšã«ã€ããŠååã¬ãã«ã§ç 究ãããã®çŸè±¡ãCOVID-19ã«äžãã圱é¿ãããã«æ·±ãç解ããã€ããã§ãããããŠããã®ç¥èŠãå¿çšããŠãCOVID-19ãžã®å¯Ÿçãææçãæå¶ããæŠç¥ãç«ãŠãããšãã§ããã°ãšèããŠããŸãããããŸã§ã¯ãæ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ãCOVID-19ãã身ãå®ãæåã®æ¹æ³ãšãªãã§ãããããšè¿°ã¹ãŠãä»åŸã®ç 究ã«æ欲ãèŠãããšåæã«ãã¯ã¯ãã³ã®æå¹æ§ãæ¹ããŠåŒ·èª¿ããŸããã
ttps://gigazine.net/news/20210324-common-cold-human-rhinovirus-coronavirus/
[å¿åãã]
?
Good!
?
Bad
ç±³ãã¡ã€ã¶ãŒãæ°åã³ããæ²»çè¬ã®æ²»éšãéå§ãçµå£å
米補è¬å€§æãã¡ã€ã¶ãŒã¯23æ¥ãæ°åã³ãããŠã€ã«ã¹ã®æ²»çè¬ã«ã€ããŠåæ段éã®èšåºè©ŠéšïŒæ²»éšïŒãéå§ãããšçºè¡šãããææè
ã®äœå
ã§ãŠã€ã«ã¹ã®å¢æ®ãé²ãäœçšãæã€ãå£ãã飲ãçµå£è¬ã§ã泚å°è¬ãªã©ã«æ¯ã¹ãŠå©äŸ¿æ§ãé«ãã®ãç¹åŸŽã ã
æ²»éšã¯ç±³åœã§å®æœãããå¥åº·ãªæ人ãæ²»éšåå è
ãšãªããåæ²»çè¬ã¯ããŠã€ã«ã¹ãäœå
ã§ææãåºããã®ã«å¿
èŠãªãããã¢ãŒãŒãšããé
µçŽ ã®åããé»ãããããã¢ãŒãŒé»å®³è¬ããšããããã¡ã€ã¶ãŒã¯äœµããŠãå
¥é¢æ£è
ã察象ã«ããéè泚å°ã§æäžããæ°åã³ããæ²»çè¬ã®æ²»éšãé²ããŠããã
åæ¥ãéºäŒåæ
å ±ããäœããã¡ãã»ã³ãžã£ãŒRNAïŒmRNAïŒããšããæ°æè¡ã掻çšããæ°ããªã¯ã¯ãã³éçºã«åãçµãæ¹éãæããã«ãªã£ãããã¡ã€ã¶ãŒã®ã¢ã«ããŒãã»ããŒã©æé«çµå¶è²¬ä»»è
ïŒCEOïŒãç±³çŽãŠã©ãŒã«ã»ã¹ããªãŒãã»ãžã£ãŒãã«ïŒWSJïŒã®ã€ã³ã¿ãã¥ãŒã§èšåããããã¡ã€ã¶ãŒè£œã®æ°åã³ããã¯ã¯ãã³ã¯ç¬ããªã³ããã¯ãšå
±åéçºããmRNAã¯ã¯ãã³ã§ããã®æåãèžãŸããŠæ°åã³ãã以å€ã®ãŠã€ã«ã¹ã«å¯Ÿå¿ããã
æ¥æ¬çµæžæ°èã2021幎3æ24æ¥
ttps://www.nikkei.com/article/DGXZQOGN23D4X0T20C21A3000000/?n_cid=SNSTW001
[å¿åãã]
?
Good!
?
Bad
ã調æ»ãïŒçè·å©Šã2å²ïŒããã€ççç¶æãããã³ãã察å¿ã§è² æ
å¢ãã³ããç
æ£ã¯æ±ãç
æ£ã ãšå¿ãªãããšãèšãããã
æ°åã³ãããŠã€ã«ã¹ææè
ã«çŽæ¥ããããçè·åž«ãã®çŽ2å²ãããã€çãªçç¶ãæããŠããããšèªæ²»åŽã®èª¿æ»ã«åçããã
ã人æäžè¶³ã®ããã«æ£è
ãžã®å¯Ÿå¿ãååã«ã§ããªãããšããææé²æ¢ã®ãã家æã«ã移åå¶éã匷ããŠããããšã§ã粟ç¥çãªè² æ
ãå¢ãããšã¿ãŠããã
ãã³ããäžã§ã®åŽåç°å¢ã«ã€ããŠãæšå¹Ž10ïœ12æã«10éçã®24å
Ǎ
é¢ã§åãçè·åž«ãæŸå°ç·æåž«ãªã©å»çåŸäºè
723人ã«å°ãã23æ¥çºè¡šããã193人ãã³ããææçæ£è
ãæ¥åžžçã«æ
åœããŠããããã¡41人ïŒ21%ïŒããã€çãªçç¶ããããšçãããæéå€å€åãå€å€ã®åæ°ãå¢ããäŒæãåãã«ãããªã£ãŠãããšããã
ãçç±ã«ã€ããŠã®èªç±èšè¿°ã§ã¯ããã³ãã察å¿ããŠããªãååããé£ã®ããã«ãŒã¯å«ã ãšèšãããããå€é£ãæ
è¡ãããã家æã«ãææ
¢ãããŠãããäŒé£ãªã©ã§ææããæ£è
ã«å¯Ÿå¿ããæã«ã¯çäžå°œããæããããªã©ã®åçããã£ãã
ãäŒèŠã«ãªã³ã©ã€ã³ã§åå ããçè·åž«ãæ©ã¿ãèªã£ããç³å·çã®å¥³æ§ã¯ãã³ããç
æ£ã¯æ±ãç
æ£ã ãšå¿ãªãããšãèšãããããšæãããé·éçã®ç·æ§ã¯ãå°ãªã人å¡ã§ã®æ£è
察å¿ã§ã¯å
å®ããã±ã¢ãã§ãããçè·åž«ãšããŠã®ä»äºããŸã£ãšãã§ããªããšãµãããªãæ°æã¡ã«ãªã£ãããšè©±ãããïŒçŽ°èŠããïŒ
ææ¥æ°è
ttps://news.livedoor.com/lite/article_detail/19899411/
[å¿åãã]
?
Good!
?
Bad
ã³ãããŠã€ã«ã¹å¯Ÿç匷åãžææçå°éå»ãè²æãå²é倧ãïŒæã«è¬åº§éèš
çãšæ±æµ·åœç«å€§åŠæ©æ§å²é倧ïŒå²éåžæ³æžïŒã¯ãæ°åã³ãããŠã€ã«ã¹å¯Ÿçã匷åãããããïŒæã«ææçå°éã®å»åž«ãªã©ãè²æããè¬åº§ãå倧å»åŠéšã«èšãããå»åž«ã®ã»ãçè·åž«ãè¬å€åž«ãèšåºæ€æ»æåž«ãªã©çå
ã®å»çåŸäºè
ãææçãå°éçã«åŠã³ãåŠè¡ç 究ãç¥èŠãçã®æœçã«ãåæ ãããïŒïŒæ¥ã«å倧ã§éãããæ¬å¹ŽåºŠã®é£æºæšé²äŒè°ã§æããã«ãããã
ãè¬åº§ã¯çã®å¯ä»ã§ãå²é倧ç
é¢çäœæ¯æŽã»ã³ã¿ãŒã®æ¯æŽãåããå倧倧åŠé¢å»åŠç³»ç 究ç§ææ¥ã»çœå®³å»åŠåéã«èšããããã³ãããã¯ãªã©çœå®³ã¬ãã«ã®ææççºçæã«ãå°åã®äºæ
ãèæ
®ããå»çäœå¶ãæ§ç¯ã§ããå»ç人æã®è²æãç®æããçå
ã®å»çæ©é¢ãçŠç¥æœèšãšé£æºããææå¶åŸ¡äœå¶ã匷åãããéèšæéã¯ïŒå¹Žãå¯ä»ç·é¡ã¯ïŒåïŒïŒïŒäžåã
ãçãšå²é倧ã¯ïŒïŒïŒïŒå¹Žã«äºãã®ç¥çã人çè³æºã掻çšããããšé£æºåå®ãç· çµããã®æ¥ã®é£æºæšé²äŒè°ã§ã森èä¹
éåŠé·ã¯è¬åº§ã®èšçœ®ã«ã€ããŠãæåŸ
ã«å¿ãããããããæ倧éåªåããŠããããšè¿°ã¹ãã
ãäŒè°ã§ã¯ã»ãã«ã倧åŠåŽãæ©æ§çŽèœã®ç 究æ ç¹ã®å®çžŸãé²æïŒã¡ããïŒãå ±åããç蟲æ¥æè¡ã»ã³ã¿ãŒãçæ°åå€åé©å¿ã»ã³ã¿ãŒãšããããé£æºããç 究æå°ããããžã§ã¯ãã®å±æã玹ä»ãçåŽã¯ãã¯ã¯ãã³æ¥çš®ã®å®æœç¶æ³ãªã©ãæ°åã³ããã«é¢ããåãçµã¿ãçºè¡šããã
ttps://www.gifu-np.co.jp/news/20210326/20210326-55941.html
[å¿åãã]
?
Good!
?
Bad
ãç±³çŸç
察çã»ã³ã¿ãŒåæé·ãããã³ããã¯æŠæŒ¢ã®ç 究æãçºçæºã2019幎ïŒæã«ãææãåºããå§ããŠããã
ãã©ã³ãåç±³æ¿æš©äžã§ç±³çŸç
察çã»ã³ã¿ãŒïŒïŒ£ïŒ€ïŒ£ïŒã®æé·ãåãããããŒãã»ã¬ãããã£ãŒã«ãæ°ã¯
æ°åã³ãããŠã€ã«ã¹ã«ã€ããŠãäžåœæ¹åçæŠæŒ¢ã®ç 究æãèµ·æºãšãã
2019幎ïŒæã«ãææãåºããå§ããŠãããšã®èŠè§£ã瀺ããã
æ°åã³ããã®ãã³ãããã¯ïŒäžçç倧æµè¡ïŒãå§ãŸã£ãå幎ã«ïŒ£ïŒ€ïŒ£ãçããŠããã¬ãããã£ãŒã«ãæ°ã¯
26æ¥ã«æŸéããããšã®ã€ã³ã¿ãã¥ãŒã§ãåç©ãããããžã®ææã
ãããã¯çããéçåç©ãæ±ã£ãŠããåžå Žããåºãã£ããšããèŠæ¹ãå«ãä»ã®èª¬ãããã
ãã®ã·ããªãªã®æ¹ãçŸå®å³ããããšã®èããæããã«ããã
æãå¯èœæ§ãé«ãèµ·æºã¯ãç 究æã ãããããæµåºããããšã¬ãããã£ãŒã«ãæ°ã¯ææã
ããã®èª¬ãä¿¡ããªã人ããããããã¯æ§ããªããæçµçã«ç§åŠã§è§£æãããã ããããšè©±ããã
ãã®äžã§ããæå³çã«è¡ããããšç€ºåããŠãããããã§ããç®çãæã£ãŠãŠã€ã«ã¹ãæŸåºãããšããŠäžåœãéé£ããŠããããã§ããªããšçºèšã
ãæŠæŒ¢ã§ïŒæã10æåœããã«ææãå§ããããšã®æšæž¬ã瀺ããã
ttps://www.bloomberg.co.jp/news/articles/2021-03-26/QQKY0GT0G1KW01
[å¿åãã]
?
Good!
?
Bad
ãã³ãããã¢ã³ãžã§ã¹ãšVasomune Therapeuticsãå
±åéçºããæ°åã³ããæ²»çè¬ãAV-001ãã第1çžèšåºè©Šéšã§å®å
šæ§ãšå¿å®¹æ§ã確èª
ã¢ã³ãžã§ã¹ãšVasomune Therapeuticsãå
±åéçºããæ°åã³ããæ²»çè¬ãAV-001ãã第1çžèšåºè©Šéšã§å®å
šæ§ãšå¿å®¹æ§ã確èª
ïŒ DIME2021.03.26
ttps://dime.jp/genre/1107779/
â FDA ãšåè°ã®äžãåæ第 2 çžèšåºè©Šéšãéå§äºå®
ã¢ã³ãžã§ã¹ãš Vasomune Therapeuticsã¯ãCOVID-19(æ°åã³ãããŠã€ã«ã¹ææç)ã«å¯Ÿããç»æçãªæ²»çè¬ïŒãã¡ãŒã¹ãã»ã€ã³ã»ã¯ã©ã¹ïŒã§ãã AV-001 ã®ç¬¬ 1 çžèšåºè©Šéšã«ãããŠãè¯å¥œãªçµæãåŸãããããšãçºè¡šããã
æ¬è©Šéšã§ã¯ãAV-001 ã®å®å
šæ§ãšå¿å®¹æ§ã確èªããã1 æ¥ 1 åã®æäžã§éçºã§ããè¬ç©åæ
ãããã¡ã€ã«ã瀺ãããã
ä»åå®æœãã第 1 çžè©Šéšã§ã¯ã20 æ³ãã 63 æ³ãŸã§ã®å¥åº·æ人 48 åã察象ã«ãAV-001 ã®ååæäžããã³é£ç¶åæäžããããã®å®å
šæ§ãå¿å®¹æ§ãè¬ç©åæ
ãè©äŸ¡ããã
æ¬è©Šéšã®æ²»éšè²¬ä»»å»åž«ã§ãã Leela Vrishabhendra å士ã¯ããAV-001 ã®ååæäžããã³é£ç¶æäžã§ãå®å
šãã€è¯å¥œãªå¿å®¹æ§ã瀺ãããããã« AV-001 㯠1 æ¥ 1 åã®æäžã§éçºãé²ãåŸãããšãè¬ç©åæ
解æçµæãã瀺ãããããšã³ã¡ã³ãããŠããã
æ¬è©Šéšã§ã¯ãAV-001 ã®ååããã³é£ç¶æäžã«ãããŠã56ÎŒg(ãã€ã¯ãã°ã©ã )/kg/æ¥ãŸã§ã 7 æ¥éé£ç¶ã§æäžããçµæãå®å
šæ§ãšå¿å®¹æ§ã確èªãããã
é節ãªæ害äºè±¡ãèšåºçã«éèŠãªèšåºæ€æ»å€ã®ç°åžžãèšåºçã«éèŠãªå¿é»å³ã®ç°åžžã¯èªããããªãã£ããè¬ç©åæ
解æçµæããããAV-001ã®å®å
šåã¯åºãããšã確èªãããã
å瀟㚠Vasomune 瀟ã¯ããããã®ããŒã¿ãç±³åœé£åå»è¬åå±ïŒFood and Drug AdministrationïŒã«æåºããŠã次ã®ã¹ãããã§ãããé床㮠COVID-19 æ£è
ã§ã®æå¹æ§ãè©äŸ¡ããåæ第 2 çžèšåºè©Šéšã«ã€ããŠåè°ããäºå®ã ã
ãªããåæ第 2 çžèšåºè©Šéšã¯ãç±³åœã«å ããŠã«ããã®æœèšãå«ããŠå®æœããããšãæ€èšããŠãããšããã
[å¿åãã]
?
Good!
?
Bad
ãã³ããæ²»çè¬ãå®®åŽå€§åŠãæ°åã³ãããäžççæ£è
ã®éçåé²ãæ²»çè¬éçºãžãå®®åŽç
ãã¬ãå®®åŽããªã³ã¯å
ã«åç»
ttps://www.umk.co.jp/news/?date=20210326&id=07962
æ°åã³ãããŠã€ã«ã¹ã®äžççæ£è
ã®éçåãé²ãæ²»çè¬ã®éçºã«åããå®®åŽå€§åŠã§ã¯6æããããèšåºè©Šéšãå§ãããšçºè¡šããŸããã
èšåºè©Šéšã¯ãæ¥æ¬å»çç 究éçºæ©æ§ã®äºæ¥ã«æ¡æãããå®®åŽå€§åŠå»åŠéšå
ç§åŠè¬åº§ã®åæåéææã®ç 究ã°ã«ãŒããè¡ããŸãã
æ²»çè¬ã®éçºã«ã¯ãåæææãçºèŠã30幎è¿ãç 究ãç¶ãããã«ã¢ã³ã®äžçš®ã¢ãã¬ãã¡ãã¥ãªã³ã䜿ãããŸãã
ã¢ãã¬ãã¡ãã¥ãªã³ã¯æ°åã³ãããŠã€ã«ã¹ãžã®ææã§çããè¡ç®¡ã®é害ã«å¯Ÿãäœã®é²åŸ¡æ©èœãé«ãããã»ãããŠã€ã«ã¹ææã«ããéå°ãªå
ç«åå¿ã«å¯ŸããŠé®éåäœçšããããšããããšã§ãã
ïŒå®®åŽå€§åŠå»åŠéšå
ç§åŠè¬åº§ãåæåéææïŒ
ãè¬ã«ããŠæ©ãæ£è
ããã®ããšããããŠæ²»çãåºæ¥ãªããŠå°ã£ãŠããå»åž«ã®ããšã«æ°ããè¬ã1æ¥ãæ©ãå±ããããšããã®ãä»ã®æ°æã¡ã§ããã
èšåºè©Šéšã«ã¯å®®åŽå€§åŠãäžå¿ã«åœå
ã®ããã20ã®å»çæ©é¢ãåå ãå®®åŽå€§åŠã§ã¯å®å
šæ§ãå«çæ§ã®å¯©æ»ãçµãŠã6æããããæ£è
ãžã®æäžãå§ãèšåºè©Šéšã¯2022幎3æãŸã§è¡ãããŸãã
[å¿åãã]
?
Good!
?
Bad
ãã³ãããã¯ã¯ãã³æ¥çš®ã第4æ³¢ã«ã¯å¹æéå®çãææããŒã¯ã¯5æäžæ¬ããç波倧ã°ã«ãŒããAIã§è©Šç®
â»NHK
æ¥æããé«éœ¢è
ãžã®æ°åã³ãããŠã€ã«ã¹ã®ã¯ã¯ãã³ã®æ¥çš®ãå§ãŸããŸãããç波倧åŠã®ã°ã«ãŒããAIïŒäººå·¥ç¥èœã䜿ã£ãè©Šç®ã§ãä»®ã«æ±äº¬éœã§å»å¹Žå€ã®ç¬¬2æ³¢ãšåãããŒã¹ã§ææãåæ¡å€§ããå Žåãã¯ã¯ãã³ã®æ¥çš®ãæ¥ãã§ã次ã®æµè¡ãæããå¹æã¯éå®çã ãšããçµæããŸãšããŸããã
ããã¯ç波倧åŠã®åæ©ç¯ä¹ææãã®ã°ã«ãŒããAIã䜿ã£ãã·ãã¥ã¬ãŒã·ã§ã³ã§è©Šç®ãããã®ã§ãã
ã°ã«ãŒãã§ã¯ãå»å¹Ž1åç®ã®ç·æ¥äºæ
宣èšã解é€ãããŠããå€ã«ç¬¬2æ³¢ãæ¥ãéãšåãã¬ãã«ã§ææãåæ¡å€§ãããšä»®å®ããŠãã¯ã¯ãã³æ¥çš®ãææã®åºããã«ã©ã圱é¿ããããè©Šç®ããŸããã
ãã®çµæãæ±äº¬éœã§ã¯ã¯ã¯ãã³æ¥çš®ãç¡ãå Žåã5æäžæ¬ã«ææã®ç¬¬4æ³¢ãããŒã¯ãšãªãã1æ¥ã®æ°èŠææè
æ°ã¯1850人ã«ãªããšããçµæãšãªããŸããã
äžæ¹ãé«éœ¢è
ã«ã¯ã¯ãã³ã®åªå
æ¥çš®ãéå§ããæ±äº¬éœã§æ¯æ¥äººå£ã®0.3ïŒ
ã«åœããããã3äž5000人ã«æ»ããªãæ¥çš®ããå Žåã§ãã5æã®ããŒã¯æã«ã¯æ°èŠææè
æ°ã¯1æ¥1650人ã§10.8ïŒ
ã®æžå°ã«ãšã©ãŸããšããèšç®ã«ãªããŸããã
æ¥çš®ã®ããŒã¹ãæ©ããæ¯æ¥äººå£ã®1ïŒ
ã«åœããããã11äž5000人ã«æ¥çš®ããå ŽåãããŒã¯æã®æ°èŠææè
ã¯1æ¥1540人ã§16.8ïŒ
æžããŸããããæµè¡èªäœãæããããšã¯ã§ããå¹æã¯éå®çãšã®çµæã«ãªããŸããã
è©Šç®ãè¡ã£ãåæ©ææã¯ã第4æ³¢ã«ã¯ã¯ã¯ãã³ã®å¹æã¯æåŸ
ã§ããªãããšãåãã£ããæµè¡ãæããå¹æãçŸãå§ããã®ã¯ãé 調ã«è¡ã£ãŠã7æ以éãªã®ã§åŒãç¶ãäŒé£æã®é£ãŸã€å¯Ÿçãªã©ãç¶ããããšãéèŠã ããšè©±ããŠããŸãã
[å¿åãã]
?
Good!
?
Bad
ãæ¥æ¬å»åž«äŒã»äžå·äŒé·ã ãå®®åçã®ç¶æ³ã¯ãïŒæïŒæ¥ã®ä»å°åžã®æçèŠè«è§£é€ãšããïœãïœãã€ãŒããåéãèŠå ãšæãããã
åçåŽåçã«ãããšã人å£ïŒïŒäžäººåœããã®çŽè¿ïŒé±éïŒïŒïŒïœïŒïŒæ¥ïŒã®æ°èŠææè
æ°ã¯ã
å®®åçãïŒïŒã»ïŒïŒäººã«äžããæ±äº¬éœïŒïŒïŒã»ïŒïŒäººïŒã倧éªåºïŒïŒïŒã»ïŒïŒäººïŒã倧ããäžåã£ãŠããã
å®®åçã§ã¯ãçé€è
æ°ãææè
æ°ãªã©è€æ°ã®ææšã§æãç¶æ³ãæ·±å»ãªãã¹ããŒãžïŒãã«éããŠããã
ïŒæïŒïŒæ¥æç¹ã§ã®ç
åºäœ¿çšçã¯ïŒïŒã»ïŒïŒ
ãšãåé±ããïŒïŒãã€ã³ã以äžæªåããŠããã
åçã§ã¯ãïŒæïŒïŒæ¥ã«æ¿åºã®é£²é£åºæ¯æŽäºæ¥ãïœãïœãã€ãŒãããçŽïŒãæã¶ãã«åéãããã
ïŒæã«å
¥ããšææãæ¥æ¡å€§ããïŒïŒæ¥ã«åã³åæ¢ã«ã
ïŒïŒæ¥ã«ã¯çãšä»å°åžãç¬èªã®ç·æ¥äºæ
宣èšãçºä»€ãã
ïŒïŒæ¥ããã¯ä»å°åžå
ã®é£²é£åºãªã©çŽïŒäžåºã«å¶æ¥æéã®ççž®ãèŠè«ããŠããã
æ¥æ¬å»åž«äŒã®äžå·ä¿ç·äŒé·ã¯å®®åçã®ç¶æ³ã«ã€ããŠãïŒæïŒæ¥ã®ä»å°åžã®æçèŠè«è§£é€ãšããïœãïœãã€ãŒããåéãèŠå ãšæãããã
ãã¡ãã£ãšããç·©ã¿ã§ããã ãã®ææè
ãåºããšããæèšã«ããªããã°ãªããªãããšææããã
ttps://www.yomiuri.co.jp/national/20210328-OYT1T50196/
åéœéåºçæšç§»ã°ã©ãæ¯èŒç»å
ttps://www.yomiuri.co.jp/media/2021/03/20210328-OYT1I50062-1.jpg
[å¿åãã]
?
Good!
?
Bad
ã³ããã«ææåŸã粟åãæžãå ±åãæµ·å€ã§çžæ¬¡ãâŠãŠã€ã«ã¹ã®äŸµå
¥ãé«ç±ã
ãæ°åã³ãããŠã€ã«ã¹ã«ææåŸã粟åãæžã£ããšããå ±åãæµ·å€ã§çžæ¬¡ãã§ãããæãæ¯ãå
èŠïŒãã
ãããïŒé害ãªã©ãæ°åã³ããã®ããŸããŸãªåŸéºçã®å®æ
ãæããã«ãªã£ãŠããããç·æ§äžåŠã®åå ã«ããªãåŸãã®ãã
â ææè
ã®4人ã«ïŒäººãç¡ç²Ÿåçã«
ãæ°åã³ããããå埩ãã43人ã®ãã¡ã4åã®1ã«ããã11人ãã粟液äžã«ç²Ÿåããªãç¡ç²Ÿåçã粟åãå°ãªãä¹ç²Ÿåçã ã£ãââã
ãã€ã¿ãªã¢ã®ç 究ããŒã ã¯3æãæ°åã³ããã«ææããç·æ§ã®ç²Ÿåã®ç¶æ
ã調ã¹ãè«æã§çºè¡šããïŒ ttps://academic.oup.com/humrep/advance-article/doi/10.1093/humrep/deab026/612516
0
å¥ãŠã€ã³ããŠã§éããŸãïŒãããŒã ã¯ç 究ã®å¯Ÿè±¡è
ã¯å°ãªãããæ°åã³ããã粟åãæžããæãããããšææãææããå Žåã¯ãçæ®æ©èœã«ã€ããŠæ³šææ·±ãçµé芳å¯ãåããã¹ãã ããšããã
ããã€ãã®ç 究ããŒã ã1æãæ°åã³ããã«ææããŠå埩ãã84人ãšãå幎代ã®å¥åº·ãª105人ã®ç²Ÿæ¶²ã60æ¥éã10æ¥ééã§èª¿ã¹ããææè
ã¯å¥åº·ãªäººã«æ¯ã¹ã粟åã«æªåœ±é¿ãäžããççãé
žåã¹ãã¬ã¹ã瀺ãæ°å€ãææã«é«ãã£ããïŒãttps://rep.bioscientifica.com/view/journals/rep/161/3/REP-20-0382.xmlå¥ãŠã€ã³ããŠã§éããŸãïŒ
ãææçã粟åã«åœ±é¿ãäžããã¡ã«ããºã ã¯ã倧ããäºã€ã«ããããã
ãäžã€ã¯ããŠã€ã«ã¹ã粟巣å
ã«å
¥âŠ
ttps://www.asahicom.jp/articles/images/AS20210323001367_comm.jpg
ttps://www.asahicom.jp/articles/images/AS20210326002463_comm.jpg
ãœãŒã¹å
ttps://www.asahi.com/articles/ASP3R446VP3LULBJ002.html?iref=comtop_7_01
[å¿åãã]
?
Good!
?
Bad
ãå»çæ©åšå€§æã»ãã«ã¢ãïŒåæ¥çš®ã®æ³šå°åšçç£ãã³ããã¯ã¯ãã³ãç¡é§ãªã
å»çæ©åšå€§æã®ãã«ã¢ã¯ïŒïŒæ¥ãç±³ãã¡ã€ã¶ãŒè£œã®æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ãïŒç¶ããïŒåæ¥çš®ã§ãã泚å°åšã®çç£ãéå§ãããšçºè¡šãããç²åºå·¥å ŽïŒå±±æ¢šçæåçºïŒã§ãïŒïŒïŒïŒå¹ŽåºŠã«ïŒïŒïŒïŒäžæ¬ãçç£ãããè¬æ¶²ãç¡é§ãªã䜿çšã§ããå¹ççãªã¯ã¯ãã³æ¥çš®ã«ã€ãªããããã ã
ãïŒæïŒæ¥ã«åçåŽåçãã補é 販売æ¿èªãååŸãããïŒæ以éé 次åºè·ãããéãšæ³šå°åšãäžäœæ§é ã®ãããè¬æ¶²ãçå
ã«æ®ãã«ããããŸããã³ãããŠã€ã«ã¹ã¯ã¯ãã³ãçè泚å°ã§ããããšãããç®äžæ³šå°ããæ·±ãå±ãããéãåŸæ¥åããïŒããªé·ãããã
æäºãããã³ã
ttps://www.jiji.com/jc/article?k=2021033100760&g=eco
[å¿åãã]
?
Good!
?
Bad
ã³ããå
¥é¢1人ã«ã€ã蚺çå ±é
¬500äžåæžã京倧æšèš
京éœå€§åŠã®ç 究ããŒã ãåæãããšãããæ°åã³ãããŠã€ã«ã¹ææçã®æ£è
ãæšå¹Ž9æãŸã§ã«åãå
¥ãã倧åŠç
é¢ãç·åç
é¢ã¯ãåå
¥ã倧ããèœã¡èŸŒãã ããšãããã£ããããŒã ã®æšèšã«ããã°æ£è
ã1人å
¥é¢ããããšã«å¹³åçŽ520äžåãéäžæ²»ç宀ïŒICUïŒãªã©ã§æ²»çããå Žåã¯å¹³åçŽ1200äžåæžå°ããã
ãæ°åã³ããæ£è
ãåãå
¥ããã»ã©ãç
é¢çµå¶ãèŠãããªããšããããã»ãã®ç
æ°ã®èšºçã«è·å¡ãæœèšãããŠã«ãããªããåå
¥ãæžãããã ãã³ããç
åºç¢ºä¿ãããããç
é¢ãå°ãªããªããšããããæ¿åºã¯å
¥é¢ãåãå
¥ããå»çæ©é¢ã«æ¯æãããã蚺çå ±é
¬ãã®é¡ãåŒãäžããŠããã
ã京倧ããŒã ã¯ãå
šåœçŽ230ã®å€§åŠç
é¢ãç·åç
é¢ããæäŸãããããŒã¿ãåæãã³ããæ£è
ã®åãå
¥ãç¶æ³ãã蚺çå ±é
¬ã«ããåå
¥ãå幎ã®åãæãšæ¯ã¹ãŠã©ãã ã£ããã調ã¹ãã
ã察象ç
é¢ã®çŽ7å²ãã³ããå
¥é¢ãåãå
¥ããŠãããå
¥é¢æ¥æ°ã¯13ã»6æ¥ã»ã©ãICUãªã©ãå©çšããæ£è
ã§ã¯15ã»4æ¥ã»ã©ã ã£ãã蚺çå ±é
¬ã«ããåå
¥ã¯ãæåã®ç·æ¥äºæ
宣èšãåºãããæéäžã®5æãããŒã¯ã«å幎ããæžå°ãã³ããæ£è
ã1æ¥å
¥é¢ããããšã«çŽ38äžåãICUãªã©ãå©çšããå Žåã¯1æ¥çŽ79äžåãåå
¥ãæžãèšç®ã«ãªã£ãã
ãæšå¹Ž5æã¯ã15æ³æªæºã®å€æ¥ã«ãã蚺çå ±é
¬ãå幎ã®åå以äžã«æžå°ãå°å
ç§ãäžå¿ãšããã³ãã以å€ã§ã®ãå蚺æ§ããã圱é¿ãããšã¿ãããããŸããçŒç§ãè³éŒ»åœåïŒããããïŒç§ãæŽåœ¢å€ç§ãªã©ã®ç·æ¥ã§ãªãæè¡ã®ä»¶æ°ã倧ããæžã£ãŠããã
ããã ãæ¿åºã¯èšºçå ±é
¬ã®å¢é¡ãšâŠ
ææ¥æ°è
[å¿åãã]
?
Good!
?
Bad
ãæ¥æ¬å»åž«äŒãäžå·äŒé·ãååŽçè·å¡ã®æ·±å€äŒé£ã«ãåœæ°ãžã®èä¿¡ãå»çé¢ä¿è
ã®åªåãèžã¿ã«ãããã®ã
â»FNN
æ¥æ¬å»åž«äŒã®äžå·äŒé·ã¯ãæ·±å€ãŸã§äŒé£ããåçåŽåçã®è·å¡ã«å¯ŸããŠãå»çé¢ä¿è
ã®åªåãèžã¿ã«ãããã®ã ãšæããšãå³ããå±è²¬(ãã£ãã)ããã
æ¥æ¬å»åž«äŒã»äžå·ä¿ç·äŒé·ãççŽã«è³ãçã£ããç·æ¥äºæ
宣èšããªããšã解é€ããç¢å
ã®ããšã§ãè¡æãåãããä»åã®ç¡èªèŠãªè¡åã¯ãåœæ°ãžã®èä¿¡ã§ãããšåæã«ãå»çé¢ä¿è
ãååã®ååŽçè·å¡ã®åªåãèžã¿ã«ãããã®ã ãšæãã
äžå·äŒé·ã¯ãæ·±å€äŒé£ããååŽçã®è·å¡ãå³ããå±è²¬ããä¿¡é Œãåãæ»ãåªåãèŠããŠã»ãããšèšŽããã
æ°åã³ãããŠã€ã«ã¹ã®çŸåšã®ææç¶æ³ã«ã€ããŠã¯ããä»ã確å®ã«ç¬¬4æ³¢ã«åãã£ãŠããããšææãããŸã延é²æ¢çéç¹æªçœ®ã®é©çšãã¡ã
ãã¡ããªãå®æœããã¹ãã ãšè¿°ã¹ãã
[å¿åãã]
?
Good!
?
Bad
ãã³ãããŠã€ã«ã¹ã æ¥å
ã¯ã³ãããŠã€ã«ã¹ãäºæž¬ãã8åéãäžæŽ»åããŸããäžçš®ã®çŽ«å€ç·èå¯
ç§åŠè
ã®ããŒã ã¯ãææ°ã®çè«ãšå®éšçµæã®éã«æçœãªççŸãããããšã«æ°ä»ããåŸãæ¥å
ãSARS-CoV-2ãã©ã®ããã«äžæŽ»åãããã«ã€ããŠã®ãã倧ããªçµæãæ±ããŠããŸãã
ã«ãªãã©ã«ãã¢å€§åŠãµã³ã¿ããŒãã©æ ¡ã®æ©æ¢°ãšã³ãžãã¢ã§ããããªãå士ã¯ãå®éšã§ã¯ãææ°ã®çè«ã¢ãã«ãäºæž¬ããããã8åãéããŠã€ã«ã¹ãäžæŽ»åãããŠããããšã«æ°ã¥ããŸããã
ãçè«ã§ã¯ãUVBããŠã€ã«ã¹ã®RNAã«åœãã£ãŠæå·ããããšã§ãäžæŽ»åãæ©èœãããšæ³å®ããŠããŸãããšããªãå士ã¯èª¬æããŸãã
ãããããã®äžäžèŽã¯ããã以äžã®ããšãèµ·ãã£ãŠããããšã瀺åããŠããããããäœã§ããããç解ããããšã¯ããŠã€ã«ã¹ã®ç®¡çã«åœ¹ç«ã€å¯èœæ§ããããŸãã
玫å€ç·ããŸãã¯ã¹ãã¯ãã«ã®çŽ«å€ç·éšåã¯ãDNAããã³RNAã®ç¹å®ã®æ žé
žå¡©åºã«ãã£ãŠå®¹æã«åžåãããåºå®ãå°é£ãªæ¹æ³ã§çµåããå¯èœæ§ããããŸãã
ãããããã¹ãŠã®çŽ«å€ç·ãåããšããããã§ã¯ãããŸããã
UVAãšåŒã°ããããé·ãUVæ³¢ã¯ãåé¡ãåŒãèµ·ããã®ã«ååãªãšãã«ã®ãŒãæã£ãŠããŸããã
埮çç©ã殺ããç§ãã¡èªèº«ã®çŽ°èã倪éœã®æå·ã®å±éºã«ãããäž»ãªåå ã¯ãæ¥å
ã®äžã®çŽ«å€ç·ã®ãããã¬ã³ãžã§ãã
çæ³¢îŠUVCîŠæŸå°ã¯ãSARS-CoV-2ãªã©ã®ãŠã€ã«ã¹îŠã«å¯ŸããŠå¹æçã§ããããšã瀺ãããŠããŸããîŠãããã§ã人éã®äœæ¶²ã«å®å
šã«å
ãŸããŠããŸãã
â
[å¿åãã]
?
Good!
?
Bad
ãããããã®ã¿ã€ãã®UVã¯ããªãŸã³å±€ã®ãããã§ãéåžžãå°çã®è¡šé¢ã«ã¯å±ããŸããã
ãUVCã¯ç
é¢ã«æé©ã§ãããšãå
±èè
ã§ãªã¬ãŽã³å·ç«å€§åŠã®æ¯ç©åŠè
ãã¯ããªãŒå士ã¯è¿°ã¹ãŠããŸãã
ããããããããã³ãå°äžéãªã©ã®ä»ã®ç°å¢ã§ã¯ãUVCã¯ç²åãšçžäºäœçšããŠæ害ãªãªãŸã³ãçæããŸããã
2020幎7æãå®éšçç 究ã«ãããã·ãã¥ã¬ãŒããããåŸæ¶²äžã®SARS-CoV-2ã«å¯ŸããUVå
ã®åœ±é¿ããã¹ããããŸããã
圌ãã¯ãã·ãã¥ã¬ãŒããããæ¥å
ã«10ã20åéããããããšãã«ããŠã€ã«ã¹ãäžæŽ»åãããããšãèšé²ããŸãããîŠ
解説ïŒçŽ«å€ç·ã®æ³¢é·æ¬¡ç¬¬ãšããããšãããã€ã«æ¥å
济ãããšãã²ãå¯èœæ§ããã
ttps://www.sciencealert.com/sunlight-inactivates-sars-cov-2-a-lot-faster-than-pr
edicted-and-we-need-to-work-out-why
[å¿åãã]
?
Good!
?
Bad
ãã€ã³ãã«ãšã³ã¶ãçŸè¡èª¿æ»ã§åã®æµè¡ãªããä»ã·ãŒãºã³æ¿æžããããã¯ïŒ
æ°åã³ãããŠã€ã«ã¹ææçã®ç·æ¥äºæ
宣èšã¯å
šéœéåºçã§è§£é€ããããã®ã®ãææè
æ°ã¯äžåã«æžå°ããæ°é
ãèŠããŠããŸãããäžæ¹ã§äŸå¹Žå€æ°ã®ææè
ãåºããŠããã€ã³ãã«ãšã³ã¶ã«ã€ããŠã¯2020幎ç§ãã2021幎æ¥ã«ãããŠãåçåŽåçã®æšèšã§å»çæ©é¢å蚺è
æ°ãçŽ1äž4000人ãšçºè¡šãããŸããã
ã€ã³ãã«ãšã³ã¶ã®æ£è
æ°ã¯ãå®ç¹ããšåŒã°ããæ¯é±å
šåœçŽ5000ã®å»çæ©é¢ããå ±åãããæ°å€ãããšã«ãå
šåœã®æ£è
æ°ãæšèšãããŠãããã®ã§ãã
äŸå¹Žã®ã€ã³ãã«ãšã³ã¶ã®ææè
æ°ã¯ãåœå
ã§æšå®çŽ1000äžäººãããšããããŠããŸãã®ã§ãä»ã·ãŒãºã³ã¯çŽ1000åã®1ã«ãæ¯èŒçæ£è
æ°ãå°ãªãã£ããšãããæšå£ã§ãçŽ728äž5000人ãšãããŠããŸããã®ã§ã500åã®1æªæºãšãªã倧å¹
ãªæžå°ãã¿ããŸããã
ãŸããæ£è
å ±åæ°ãæµè¡ã®ç®å®ãšãããæ°Žæºã«éããããšãªãã·ãŒãºã³ãçµããã®ã§ããæµè¡å
¥ãããããšãªãã·ãŒãºã³ãçµããã®ã¯ãä»ã®æ¹æ³ã§èª¿æ»ãå§ãŸã£ã1999幎以éã§åããŠã ãšããããšã§ãã
ã€ã³ãã«ãšã³ã¶ã ãã§ãªãããã®å¬ã¯é¢šéªãã²ã人ãæžå°åŸåã«ããããã§ãããŠã§ã¶ãŒãã¥ãŒã¹ã§ãã®å¬ã®é¢šéªã«é¢ããã¢ã³ã±ãŒã調æ»ãå®æœãããšããã颚éªãã²ããåæ°ãæžã£ããšåçãã人ã62%ã§ãå¢ãã(2%)ã倧ããäžåãçµæãšãªããŸããã
ä»å¹Žã¯ã©ãããŠã€ã³ãã«ãšã³ã¶ãæµè¡ããªãã£ãã®ã§ãããããã€ã³ãã«ãšã³ã¶æ£è
æžå°ã®çç±ã«ã€ããŠãææçã«è©³ãã暪æµé¶ŽèŠãªãããªããŒã·ã§ã³ç
é¢(暪æµåžé¶ŽèŠåº)ã®åç°åæé¢é·ã«äŒºããŸããã
[å¿åãã]
?
Good!
?
Bad
ãã¹ã¯ãææŽããªã©ã®æ°åã³ãããŠã€ã«ã¹å¯Ÿçãå¥å
ãã€ã³ãã«ãšã³ã¶æ£è
ãä»å£å€§å¹
ã«æžå°ããããšã«ã¯ããã€ãã®çç±ãèããããŸãããå€ãã®äººãæ°åã³ãããŠã€ã«ã¹ã®ææäºé²ã§ãã¹ã¯ãææŽããããŠããããšããã€ã³ãã«ãšã³ã¶æ£è
ãæžãããŠãããã®ãšæãããŸããã€ã³ãã«ãšã³ã¶ãæ°åã³ããåæ§ã«é£æ²«ãšæ¥è§Šã§ææããã®ã§ãã³ãã察çãã€ã³ãã«ãšã³ã¶äºé²çã«ãªã£ãŠããã®ã§ãããã
ããã«2021幎ã¯3æ以éã®æž¡èªå¶éã«ãã£ãŠæµ·å€ãšã®äººç亀æµãæžå°ããããšããã€ã³ãã«ãšã³ã¶æ£è
ãæžãããŠãããšèããããŸããæµè¡ãå幎ãããååçãå£ç¯ãåããæµè¡ããŠããç±åž¯ã»äºç±åž¯å°åããã®å
¥åœè
ãå¬å£ã®ã€ã³ãã«ãšã³ã¶æµè¡ã«é¢äžããŠãããšèšãããŠããŸãããããã£ã人ç亀æµã®æžå°ãæµè¡ãæããŠãããšæãããŸãã(åç°é¢é·)
ä»å£ã¯ååçã®ãªãŒã¹ãã©ãªã¢ããã¥ãŒãžãŒã©ã³ãã§ãã€ã³ãã«ãšã³ã¶ã®æµè¡ããªãã£ããšãããŠããŸããååçãšååçã®äººç亀æµãã€ã³ãã«ãšã³ã¶ã®æµè¡ã®äžå ã ã£ãã®ãããããŸããã
ã3ã€ç®ã®çç±ã¯ãæ©ãææããè¡ãããã€ã³ãã«ãšã³ã¶ã®ã¯ã¯ãã³æ¥çš®ããããããŸããæ°åã³ãããšã®åææµè¡ãããåŸãããšãããã¯ã¯ãã³æ¥çš®ãåçºãããå€ãã®äººãæ¥çš®ããããšã§ã€ã³ãã«ãšã³ã¶æ£è
ãæžã£ãŠãããšèããããŸãã(åç°é¢é·)
(ãªã³ã¯å
ã«ç¶ããã)
ttps://weathernews.jp/s/topics/202103/310155/
2021/04/04 07:45
ãŠã§ã¶ãŒãã¥ãŒã¹
[å¿åãã]
?
Good!
?
Bad
ãã³ããã倧éªã®éçè
åãç
åºäœ¿çšçïŒïŒïŒïŒïŒ
4æ04æ¥ã20æ12å
倧éªåºå
ã®ããã«å
¥é¢ã§ããç
åºã®æ°ãšãããã©ãã ãåãŸã£ãŠãããã瀺ããç
åºéçšçãã¯æ¬¡ã®ãšããã§ãã
ïŒæ¥ã®æç¹ã§ãéçæ£è
çšã®ç
åºã¯ãå®éã«éçšãããŠããç
åºãïŒïŒïŒåºãæ£è
ãïŒïŒïŒäººã§ããç
åºéçšçããïŒïŒ.ïŒïŒ
ãšãªã£ãŠããŸãã
ãŸãã軜çã»äžççã®æ£è
çšã®ç
åºã¯ãå®éã«éçšãããŠããç
åºãïŒïŒïŒïŒåºãæ£è
ãïŒïŒïŒäººã§ãéçšçã¯ïŒïŒ.ïŒïŒ
ã
ç¡çç¶ã®äººãªã©ãçé€ããããã«å©çšããããã«ãªã©ã®å®¿æ³çé€æœèšã®éšå±ã¯ãå®éã«éçšãããŠããéšå±ãïŒïŒïŒïŒå®€ã宿æ³çé€è
ãïŒïŒïŒäººã§ãéçšçã¯ïŒïŒ.ïŒïŒ
ãšãªã£ãŠããŸã
ttps://www3.nhk.or.jp/kansai-news/20210404/2000043477.html
[å¿åãã]
?
Good!
?
Bad
ã尟身äŒé·ãæ±äº¬ã倧éªã®ãããªç¶æ³ã«ãªãå¯èœæ§ãã
â»ãã€ã¿ãŒ
æ±äº¬ãïŒæ¥ããã€ã¿ãŒïŒœ - æ¿åºã®ææç察çåç§äŒã®å°Ÿèº«èäŒé·ã¯ïŒæ¥ã®åé¢æ±ºç®å§å¡äŒã§ãæ°åã³ãããŠã€ã«ã¹ã®ææç¶æ³ã«ã€ããŠãæ±äº¬ãïŒææã®æ¡å€§ãç¶ãïŒå€§éªã®ãããªç¶æ³ã«ãªãå¯èœæ§ãããããšããããããç¶æ³ãåé¿ããããããã©ããªå¹æçãªå¯ŸçãæãŠãã®ããçå£ã«æ€èšãã¹ãææã«å
¥ãã€ã€ããããšè¿°ã¹ããå€è³ä¹å£«å§å¡ïŒç«æ²æ°äž»ïŒã®è³ªåã«çããã
尟身äŒé·ã¯ãæ±äº¬ã®ææç¶æ³ã«é¢ããïŒïŒé±åäœã§åé±æ¯å¢å ãïŒé±ç¶ç¶ããŠãããïŒïŒå€ç°æ ªã®å²åãåŸã
ã«å¢ããŠãããïŒïŒç·æ¥äºæ
宣èšè§£é€ïŒïŒæïŒïŒæ¥ïŒåŸã«äººæµãå¢å åŸåã«ããââãšææã人æµã®å€åã®åœ±é¿ãä»åŸãïŒãïŒé±éã§åºãŠããããšãèãããããšèªã£ãã
æ°åã³ãã察çå
šè¬ã«ã€ããŠã¯ãã¯ã©ã¹ã¿ãŒã®å€æ§åãè¡åå€å®¹ã«å¯ŸããååãåŸããã«ãããªã£ãŠããŠããããšãªã©ãèžãŸãããšããå€æ§ãªæææºã«ãããçŽæ¥çã«ä»å
¥ããããšãæ±ããããŠããããšèšŽããã
2021幎4æ5æ¥ / 12:19 ååŸ
[å¿åãã]
?
Good!
?
Bad
ãéºäŒå泚å°ããæ°å¹Žä»¥å
ã«ã¬ã³ã®mRNAã¯ã¯ãã³éçºãæ°åã³ããã¯ã¯ãã³ããã¡ã€ã¶ãŒãšå
±åéçºããããªã³ããã¯åµæ¥è
ã蚌èš
ãæ°å¹Žä»¥å
ã«ã¬ã³ã®ã¯ã¯ãã³éçºãæ°åã³ããã¯ã¯ãã³ããã¡ã€ã¶ãŒãšå
±åéçºããããªã³ããã¯åµæ¥è
ã蚌èš
FINDERSãå±±ç°å±±å€ªã2021/04/02
ttps://finders.me/articles.php?id=2698
ãã¥ã¬ã·æ°ãšå€«ã®ãµãã³æ°ã¯å
æããã€ãã®ã·ã¥ã¿ã€ã³ãã€ã€ãŒå€§çµ±é ãããã¡ãªããå²ç« ãäžããããã
ttps://www.youtube.com/watch?v=9tKagkouX3M&feature=emb_logo
ç涯ã§2人ã«1人ã眹æ£ãã3人ã«1人ãæ»äº¡ãããšèšãããŠãããã¬ã³ããçŸåšã®å»çã§ã¯ããŸã ãã¹ãŠã®ã¬ã³ãæ²»ãããšã¯åºæ¥ãªãç¶æ³ã ããããããã®ã¬ã³ãããã人é¡ã¯å
æããããšãã§ããããã«ãªããããããªãã
â mRNAãããŒã¹ã«ã¬ã³ã®ã¯ã¯ãã³ãéçº
ãªãºã¬ã ã»ãã¥ã¬ã·æ°ãšå€«ã®ãŠã°ã«ã»ãµãã³æ°ã«ãã£ãŠèšç«ããããã€ãã®BioNTech瀟ã¯ããã¡ã€ã¶ãŒãšãšãã«æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã®éçºã«æåããäžççãªè©äŸ¡ãéããããKABC Newsãã«ããã°ã2人ã¯äœã®å
ç«ã·ã¹ãã ãå©çšããŠè
«çãæ²»çããç 究ãé·å¹Žè¡ã£ãŠãããä»åã®ã¯ã¯ãã³éçºã«ãã®æè¡ã掻ããããã¡ãã»ã³ãžã£ãŒRNAïŒïœRNAïŒã䜿ããç¹å®ã®ãŠã€ã«ã¹ãæ»æããããã®ã¿ã³ãã¯è³ªãäœãããã«äººäœã«æ瀺ãåºããã®ã ã
ãã¥ã¬ã·æ°ã«ãããšããã®åçãçšããŠãå
ç«ç³»ã®è
«çã«å¯ŸããŠæ»æãè¡ãæ瀺ãåºãããšãå¯èœã§ãããšããããç§ãã¡ã¯mRNAãããŒã¹ã«ãããã¬ã³ã®ã¯ã¯ãã³ãæ°çš®é¡éçºããŠããŸãããšãAPéä¿¡ã®åæã«çããã
ããã«ããã¥ã¬ã·æ°ã¯ã¬ã³ã®ã¯ã¯ãã³ãå®çšåããããŸã§ã®æéã«ã€ããŠããé©æ°çãªæè¡éçºã«ãããŠãããã£ãæéãäºæž¬ããã®ã¯ãšãŠãé£ããããšã§ãããæ°å¹Žä»¥å
ã«ã¯ç§ãã¡ãéçºããã¯ã¯ãã³ã人ã
ã«æäŸã§ããã®ã§ã¯ãšæåŸ
ããŠããŸãããšé©ãã®èšŒèšãããã
[å¿åãã]
?
Good!
?
Bad
â ã¯ã¯ãã³éçºã¯å€ãã®äººã®åªåã®äžã«
ãã¥ã¬ã·æ°ãšå€«ã®ãµãã³æ°ã¯å
æããã€ãã®ã·ã¥ã¿ã€ã³ãã€ã€ãŒå€§çµ±é ãããã¡ãªããå²ç« ãäžããããããã¥ã¬ã·æ°ã¯ä»åã®åè³ã«ãæ¬åœã«åèªã§ããã倫ãç§ãæåããŠããŸãããšçããããã¯ã¯ãã³ã®éçºã¯å€ãã®äººã®åªåã«ãã£ãŠåºæ¥äžãã£ããšè¿°ã¹ãããBioNTech瀟ã®ããŒã ãšããŒãããŒäŒæ¥ãããã«æ¿åºé¢ä¿è
ãèŠå¶åœå±ãå±æ©æããã£ãŠååãããå€ãã®äººã®åªåã®è³ç©ã§ãããšãã¥ã¬ã·æ°ããããã¯åªåãå®ãçµãã ãã®ã§ãããç§åŠã称ãããã®ã§ãããŸãããšãã
ããã人é¡ãã¬ã³ãå
æããããšãã§ããããã«ãªãã°ãå»çã¯ãã¡ããã瀟äŒã®ããæ¹ãã®ãã®ã«å€§ããªåœ±é¿ãäžãããããããªããä»åŸã®ãã¥ã¬ã·æ°ãã®æŽ»èºã«æåŸ
ãããã
ãã€ãã®å
èšäº
Scientist behind Pfizer's coronavirus vaccine says next target is cancer
ttps://abc7ny.com/10432958/?ex_cid=TA_WABC_TW&taid=60555e313d8739000199dea2&utm_
campaign=trueAnthem:+Trending+Content&utm_medium=trueAnthem&utm_source=twitter
[å¿åãã]
?
Good!
?
Bad
ãç 究ææãT现èã¯æ°åã³ãããŠã€ã«ã¹ã®å€ç°æ ªãèªèã§ããããšãææ°ã®ç 究ã§æããã«
1床æ°åã³ãããŠã€ã«ã¹ææç(COVID-19)ã«çœ¹ã£ã人ããã¯ã¯ãã³ãæ¥çš®ãã人ã察象ã«ããææ°ã®èª¿æ»ããããªã³ãçã®äžçš®ã§ãããT现èããæ°åã³ãããŠã€ã«ã¹(SARS-CoV-2)ã®å€ç°æ ªãèªèããããšãæããã«ãªããŸãããããã«ããã1床COVID-19ã«çœ¹ã£ãŠå埩ãã人ããã¯ã¯ãã³ãæ¥çš®ãã人ã¯ãçåšãæ¯ããå€ç°æ ªã«å¯ŸããŠãå
ç«ãçºæ®ã§ããå¯èœæ§ã瀺åãããŠããŸãã
T cells recognize recent SARS-CoV-2 variants | National Institutes of Health (NIH)
ttps://www.nih.gov/news-events/news-releases/t-cells-recognize-recent-sars-cov-2
-variants
2020幎åŸåã«åºçŸãå§ããæ°åã³ãããŠã€ã«ã¹ã®å€ç°æ ªã¯ããããŸã§ã«æ°åã³ãããŠã€ã«ã¹ã«ææãã人ãã¯ã¯ãã³ãæ¥çš®ãã人ã§ãã£ãŠãææããå±éºæ§ãæžå¿µãããŠããŸãããããã§ãã¢ã¡ãªã«åœç«ã¢ã¬ã«ã®ãŒã»ææçç 究æ(NIAID)ã¯1床COVID-19ãæ£ã£ãŠå埩ãã30人ã®è¢«éšè
ããè¡æ¶²ãæ¡åããè¡çãµã³ãã«ãåæãããšãã調æ»ãè¡ã£ãŠããŸãã
[å¿åãã]
?
Good!
?
Bad
調æ»ã§ã¯ã1床COVID-19ã«ææããŠå埩ãã被éšè
ã®è¡äžCD8ïŒT现èããSARS-CoV-2ã®å€ç°æ ªã§ãããB.1.1.7ããB.1.351ããB.1.1.248ãã®3çš®ãèªèã§ãããåŠãã調ã¹ãŠããŸãããããã®3ã€ã®å€ç°æ ªã¯äž»ã«çŽ°èã«ä»çããŠäŸµå
¥ããããã®ã¹ãã€ã¯ã¿ã³ãã¯è³ªã«å€ç°ããããã®ã§ããã¹ãã€ã¯ã¿ã³ãã¯è³ªã®å€ç°ã¯ææãŸãã¯ã¯ã¯ãã³æ¥çš®åŸã«ãå
ç«ç³»ã®B现èã§ç£çãããT现èããã³äžåæäœã«å¯Ÿããèªèãäœäžãããå¯èœæ§ãææãããŠããŸãã
èšäºäœææç¹ã§ã¯ãSARS-CoV-2ã«å¯Ÿããå
ç«ãéæããã®ã«å¿
èŠãªæäœããã³T现èå¿çã®æ£ç¢ºãªã¬ãã«ãçµæã«é¢ãã詳现ã¯äžæã§ããããããç 究è
ãã¡ã¯å¹æçãªå
ç«å¿çãè¡ãã«ã¯ãæäœãšT现èã®äž¡æ¹ãã匷åã§å¹
åºãå¿çãå¿
èŠã§ãããšæ³å®ããŠããŸãããããŠãå
ç«åå¿ã«ãããŠéèŠãªåœ¹å²ãæ
ãCD8ïŒT现èã¯ãææ现èã®è¡šé¢ã«ååšãããŠã€ã«ã¹ã¿ã³ãã¯è³ªã®äžéšãèªèããããããç Žå£ããããšã§ãŠã€ã«ã¹ãžã®ææãäºé²ããŸãã
調æ»ã®çµæãCD8ïŒT现èã¯SARS-CoV-2ã®å€ç°æ ª3çš®ãã¹ãŠãèªèã§ããããšãæããã«ãªã£ãŠããŸããNIAIDã¯ããã倧èŠæš¡ãªç 究ãå¿
èŠããšæ³šæåèµ·ããŠããŸãããããããã1床COVID-19ã«ææããŠå埩ãã人ããã¯ã¯ãã³æ¥çš®è
ã®T现èå¿çã¯ã3ã€ã®å€ç°æ ªã§èŠãããçªç¶å€ç°ã®åœ±é¿ãã»ãšãã©åãããæ°ããå€ç°äœãããäœãå®ã£ãŠãããã¯ãã§ãããšãèšããŠããŸãã
ãªããç 究ã°ã«ãŒãã¯SARS-Cov-2ã«å¯Ÿããæé©ãªå
ç«ã«ã¯ãäžåæäœããã®ä»ã®å¿çã«å ããŠãæ¢åã®SARS-Cov-2ãæ°ããå€ç°æ ªãã人äœãä¿è·ããããã®ãããŸããŸãªT现èå¿çãå¿
èŠã«ãªãå¯èœæ§ãé«ããšææããŠããŸããå ããŠãå€ç°æ ªã«å¯ŸããŠè¿œå ã®ã¯ã¯ãã³æ¥çš®ãå¿
èŠãåŠããå€æããããã«ãCOVID-19ããå埩ãã人ãã¯ã¯ãã³ãæ¥çš®ãã人ã®T现èå¿çã®å¹
ã倧ãããèä¹
æ§ãç£èŠããããšã®éèŠæ§ãç 究ã°ã«ãŒãã¯åŒ·èª¿ããŠããŸãã
[å¿åãã]
?
Good!
?
Bad
ã幎å200äžå以äžã®75æ³ä»¥äžã®å»çè²»çªå£è² æ
ããå»çè²»2å²ãæ³æ¡ã8æ¥å¯©è°å
¥ããè¡é¢
ãå»çè²»2å²ãæ³æ¡ã8æ¥å¯©è°å
¥ããè¡é¢
æäºéä¿¡4/6(ç«) 12:33é
ä¿¡
ãè¡é¢è°é¢éå¶å§å¡äŒã¯6æ¥ã®çäºäŒã§ã幎å200äžå以äžã®75æ³ä»¥äžã®å»çè²»çªå£è² æ
ã1å²ãã2å²ã«åŒãäžããå»çå¶åºŠæ¹é©é¢é£æ³æ¡ã«ã€ããŠã8æ¥ã®æ¬äŒè°ã§è
矩åéŠçžãåºåžããŠè¶£æšèª¬æãšè³ªçãè¡ãã審è°å
¥ãããããšã決ããã
[å¿åãã]
?
Good!
?
Bad
ãå»ççŸå Žã®æ²çãªå£°ã ã³ããã¯ã¯ãã³ã¯ãã€å±ãã®ãã çäžžè
°ã§ãæ¥ã
蚺çãç¶ããŠãã
ã¯ã¯ãã³ã¯ãã€å±ãã®ãå»ççŸå Žã®æ²çãªå£°
ä¹
äœ è±äº : ããã¿ã¹ã¯ãªããã¯å
ç§å»åž«
ã¯ã¯ãã³ãå»çåŸäºè
ã«å±ããªãã4æåã°ã«ã¯é«éœ¢è
ãžã®æ¥çš®éå§ãäºå®ãããŠãããšããã®ã«ãæ¬åœã«éã«åãã®ãã
ãããä»ã®æ¥æ¬ã®å»ççŸå Žã®çŽ æŽãªããããåå®ãªçåã ã
ååŽçã®çºè¡šã«ããã°ãåœå
ã§ã¯4æ2æ¥ãŸã§ã«109äž6698åã®æ¥çš®ãè¡ããããšããã
å»çåŸäºè
ã ãã§ã480äžäººãããšããã®ã«ãåçŽèšç®ã§ãããŸã 4åã®1ããã«ããŒã§ããŠããªãïŒ2åæ¥çš®ãªã®ã§å®éã«ã¯ãã£ãšå°ãªãïŒã
ããã¿ã¹ã¯ãªããã¯ãé çªåŸ
ã¡ãããŠããå»çæ©é¢ã®1ã€ã ã
æ°åã³ããã¯ã¯ãã³æ¥çš®ã®å®æœæ©é¢ãšããŠæãæããPCRæ€æ»ãè¡ã£ãŠãããã¹ã¿ãããžã®æ¥çš®ã¯å¿
é ã ã
ã ãè¡æ¿ããã®é£çµ¡ã¯ãŸã ãªããçäžžè
°ã§ãæ¥ã
蚺çãç¶ããŠããã
ttps://toyokeizai.net/articles/-/420749
[å¿åãã]
?
Good!
?
Bad
ãæ¿åºã ã³ããã¯ã¯ãã³æ³šå°ã®è·çš®æ¡å€§ãæ¯ç§å»ãªã©æ€èš
æ¥çµãªã³ã©ã€ã³
æ¿åºã¯æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã®æ¥çš®ã§æ³šå°ãæãŠãè·çš®ã®æ¡å€§ãæ€èšããã
å»åž«ãšçè·åž«ã«éå®ããçŸè¡æ³ã®èŠå¶ãç·©åããæ¯ç§å»åž«ãªã©ãæ¥çš®ãæ
ããããã«ããã
å»åŠçãã掻çšããæµ·å€ã®åãçµã¿ãåèã«æ¥çš®æ¡å€§ããããã
æ°åã³ããã®ã¯ã¯ãã³ã¯12æ¥ãã3600äžäººã®é«éœ¢è
åãæ¥çš®ãå§ãŸãã
ç¶ããŠåºç€çŸæ£ããã人ãäžè¬ã®äººãžãæ¥çš®ããããå¿
èŠãªäººå¡ãæ¥æ¿ã«å¢ããã
æ¿åºã¯ãã®åã«è·çš®æ¡å€§ãå¯èœããæ¢ãã
[å¿åãã]
?
Good!
?
Bad
ãæ¶é²ãã³ããçŠã§ææ¥åºåãæ¬éã¯æžã£ããã®ã®èªæ®ºè
æ°ã¯å¢å ãž
3æ26æ¥ãæ¶é²åºã¯ã什åïŒå¹Žäžã®ææ¥åºå件æ°çïŒéå ±å€ïŒããçºè¡šãããæŠèŠã«ããã°ãææ¥åºå件æ°ã¯å幎æ¯ã§10.6ïŒ
æžãæ¬é人å¡ã¯11.4ïŒ
æžãšãšãã«å幎æ¯ã§ã®æžå°ãæãããŠãããããããæžå°ã¯2008幎以æ¥ã12幎ã¶ãã ãšããŠãããã³ããçŠã«ããè¡çæèã®åäžãå€åºèªç²ã®çµæãæ¥ç
ã亀éäºæ
ãªã©ãæžå°ãããšããŠããããã®äžæ¹ã§ã¿ã¬ã³ãã«ããããã«èªæè¡çºã ãã¯å¢å ããŠããããŸãèŠå¯åºã3æ16æ¥ã«çºè¡šããããŒã¿ã§ã2020幎ã®èªæ®ºè
æ°ã¯å幎ãšæ¯ã¹ãŠçŽ4.5ïŒ
å¢ãšãªã£ãŠããïŒä»€åïŒå¹Žäžã®ææ¥åºå件æ°çïŒéå ±å€ïŒ[PDF]ã什åïŒå¹Žäžã«ãããèªæ®ºã®ç¶æ³[PDF]ïŒã
pongchang æ°ãã
ã什åïŒå¹Žäžã®ææ¥åºå件æ°çïŒéå ±å€ïŒãã®å
¬è¡šã什å3幎3æ26æ¥æ¶é²åºã«ãªãããã
什åïŒå¹Žäžã®ææ¥èªåè»ã«ããææ¥åºå件æ°ã¯ 593 äž 3,390 件ïŒ70 äž 6,377 件æžã10.6ïŒ
æžïŒãæ¬é人å¡ã¯529 äž4,045 人ïŒå¯Ÿå幎æ¯68 äž3,963 人æžã11.4ïŒ
æžïŒã§ææ¥åºå件æ°ãæ¬é人å¡ãšãã«å¯Ÿå幎æ¯ã§æžå°ããã
ïŒæ°åã³ãããŠã€ã«ã¹ææçãžã®å¯Ÿå¿ãªã©ãèæ¯ã«ã察å幎æ¯ã§å»¶äŒžãããšãããïŒçŸå Žå°çæèŠæéãç
é¢å容æèŠæéçã®å
šåœã®ç¶æ³ã«ã€ããŠã¯ãäŸå¹Žãšåæ§ãç¢ºå ±å€ã®å
¬è¡šã«éããŠãã瀺ãããäºå®
è¡šïŒ äºæ
çš®å¥ã®ææ¥åºå件æ°å¯Ÿå幎æ¯ãã¿ããšãèªæè¡çºã ãã¯ä»€å2幎54,924件ãšã什åå
幎ã®52,286件ã«èŒã¹ã2,638件ã»5.0ïŒ
å¢ããŠããã
什åïŒå¹ŽïŒæ16æ¥ã«åçåŽåçèªæ®ºå¯Ÿçæšé²å®€ãšèŠå¯åºç掻å®å
šå±ç掻å®å
šäŒç»èª²ãçºè¡šãã什åïŒå¹Žäžã«ãããèªæ®ºã®ç¶æ³ã§ã4.5ïŒ
å¢å ããŠãããèªæè¡çºã§ãåæ§ã®å²åã§å¢å ããŠããã
ãâ什åïŒå¹Žã®èªæ®ºè
æ°ã¯21,081人ãšãªãã察å幎æ¯912人ïŒçŽ4.5ïŒ
ïŒå¢ã
âç·å¥³å¥ã«ã¿ããšãç·æ§ã¯11幎é£ç¶ã®æžå°ã女æ§ã¯ïŒå¹Žã¶ãã®å¢å ãšãªã£ãŠãããã
ttps://srad.jp/story/21/04/06/0145237/
[å¿åãã]
?
Good!
?
Bad
æ°åã³ããã®ãæžå¿µãããå€ç°æ ªãã®åºçŸã«ããã¯ã¯ãã³ã ãã§ã¯äžååã«ãªã£ããšã®ææãå°é家ã¯ãæ倧éã®æå¶æŠç¥ãã®å®æœãæèš
æ»èªå¶ã®å»åŠéèªã»The Lancetãèšç«ããåœéçãªæ°åã³ãããŠã€ã«ã¹ææç(COVID-19)察çå§å¡äŒã§ããLancet COVID-19 Commission Taskforce on Public Healthã®å°é家ãããæ°åã³ãããŠã€ã«ã¹(SARS-CoV-2)ã®å€ç°æ ªã®ãŸã延ã«ããããã¯ãã¯ã¯ãã³ã ãã§ã¯åå©ã¯ä¿èšŒãããªãããšã®å£°æãçºè¡šããååœã®ä¿å¥åœå±ã«å¯ŸããŠåŒ·åãªå
¬è¡è¡ç察çãç¶ç¶ããããæ±ããæèšãè¡ããŸããã
New COVID variants have changed the game, and vaccines will not be enough. We need global 'maximum suppression'
ttps://theconversation.com/new-covid-variants-have-changed-the-game-and-vaccines
-will-not-be-enough-we-need-global-maximum-suppression-157870
ãã¥ãŒãžãŒã©ã³ãã»ãªãŒã¯ã©ã³ã倧åŠã®å
¬è¡è¡çåŠææã§ãLancet COVID-19 Commission Taskforce on Public Healthã®å
±åè°é·ãåããã¯ãªã¹ã»ããŒã¬ã³æ°ã8人ã®å°é家ãã¯ãåŠè¡ç³»ã¡ãã£ã¢ã»The Conversationã«å¯çš¿ããèšäºã®äžã§ã2020幎æ«ãŸã§ã¯ãã¯ã¯ãã³æ¥çš®ãååã«è¡ãããããšã«ããã人é¡ãCOVID-19ã®åå ãŠã€ã«ã¹ã§ããSARS-CoV-2ã«å¯ŸããŠåªäœã«ç«ã€ããšãã§ãããšåŒ·ãæåŸ
ãããŠããŸãããããããæ°ãã«ãæžå¿µãããå€ç°æ ª(Variants of ConcernïŒVOC)ããåºçŸãäžçäžã«ææãæ¡å€§ããŠãããããã¯ã¯ãã³ãå«ãçŸè¡ã®ãã³ãããã¯å¯Ÿçã§ã¯èšç»ãé æ«ãããããããããŸãããšææãã¯ã¯ãã³ãCOVID-19ããã®å埩ã«ããç²åŸãããå
ç«ã§ã¯ã察åŠãã§ããªãå€ç°æ ªãç»å Žãããªã¹ã¯ãé«ãŸã£ãŠããããšã«å¯Ÿããæžå¿µãè¡šæããŸããã
[å¿åãã]
?
Good!
?
Bad
ãããŸã§ååšã確èªãããŠããVOCã¯ã以äžã®3çš®ã§ãã
1ïŒåã¢ããªã«ã§åããŠå ±åãããB.1.351
2ïŒã€ã®ãªã¹ã§åããŠå ±åãããB.1.1.7
3ïŒãã©ãžã«ããæ¥æ¬ãžã®æž¡èªè
ã§ç¢ºèªãããP.1
ãããã®å€ç°æ ªã«å¯Ÿããã¯ã¯ãã³ã®å¹æã¯æªç¥æ°ã§ããäŸãã°ãã€ã®ãªã¹ã§çºèŠãããB.1.1.7ã«å¯ŸããŠã¯ããã¡ã€ã¶ãŒè£œã®ã¯ã¯ãã³ãšã¢ã¹ãã©ãŒãã«è£œã®ã¯ã¯ãã³ã®äž¡æ¹ãæ©èœãããšèããããŠããŸãããæå¹æ§ãäœäžãããšã®æžå¿µããããŸãã
ãŸãã2021幎3æãŸã§ã®æç¹ã§å°ãªããšã48ã«åœã§æ€åºãããŠããB.1.351ã¯ããããŸã§ç¢ºèªãããŠããå€ç°æ ªããææåãçŽ50ïŒ
é«ããå
ç«ã«ããé²åŸ¡ãéšåçã§ãããªããšã®ããšãããã«ãB.1.351ã¯è»œåºŠããäžç床ã®COVID-19æ£è
ã«å¯Ÿããã¢ã¹ãã©ãŒãã«è£œã¯ã¯ãã³ã®å¹æãäœäžãããå¯èœæ§ããããšã®å ±åããªãããŠããŸãã
ããããçç±ãããããŒã¬ã³æ°ãã¯ã䌌ããããªå€ç°ãããŸããŸãªåœã§åæã«çºçããŠãããšããããšã¯ãåœå¢ç®¡çãã¯ã¯ãã³æ¥çš®ããã£ããããŠããå°åã§ãã£ãŠãããã®å°åã§COVID-19ã®ææãããªãé²ãã§ããå Žåã¯ãèªåœç£ã®å€ç°ããåœæ°ãå®ãããšã¯é£ãããšããããšãæå³ããŠããŸãããã®ãããå°å瀟äŒã§ã®ãŸã延ãé£ãæ¢ããã®ãèèŠã§ããSARS-CoV-2ã®æ¡æ£ãé²ãã«ã¯ãåäžã®å¯Ÿçã§ã¯äžååãªã®ã§ãååœã¯ã¯ã¯ãã³æ¥çš®ãšäžŠè¡ããŠåŒ·åãªå
¬è¡è¡ç察çãç¶æããããšãã€ãŸãã(PDFãã¡ã€ã«)æ倧éã®æå¶ããè¡ãå¿
èŠããããŸãããšè¿°ã¹ãŸããã
ããŒã¬ã³æ°ããæå±ãããæ倧éã®æå¶ããšã¯ããããŸã§è¡ãããŠããææ察çã培åºããããšã§ãæåéãSARS-CoV-2ã®æææ¡å€§ãæ倧éã«æå¶ããããšã§ããå
·äœçã«ã¯ãã¹ã¯ã®ççšãç©ççãªè·é¢ã眮ãããšã宀å
ã®ææ°ãªã©ã§ãã
[å¿åãã]
?
Good!
?
Bad
ããŒã¬ã³æ°ãã«ãããšããŠã€ã«ã¹ã1åè€è£œãããããšã«çªç¶å€ç°ããæ©äŒã3åçºçãããšã®ããšããã®ããããŠã€ã«ã¹ã®ææçãå¯èœãªéãäœæžãããããšããVOCã®åºçŸãæããäžã§éèŠã ãšããŒã¬ã³æ°ãã¯åŒ·èª¿ããŠããŸãã
ããããç¹ããããŒã¬ã³æ°ãã¯ã誰ããCOVID-19ããå®å
šã«ãªããŸã§ãæ¬åœã«å®å
šãªäººã¯ããŸãããç§ãã¡ã¯ãæ°ããå€ç°æ ªãåºçŸããåã«ãæ¡æ£ãé²ãã§äžççãªCOVID-19ææçãååã«äœãããªããã°ãªããªããšããæéãšã®æŠãã匷ããããŠããŸããå€ãã®åœã§ã¯ããŠã€ã«ã¹ã®ã²ãã ãåæããŠæ°ããå€ç°æ ªãã©ããã調ã¹ãèœåã¯ãããŸãããã€ãŸããæ¢ã«VOCãå°ãªããšã3ã€çºèŠãããŠãããšãããã®ç¶æ³ã¯ãèŠãç®ä»¥äžã«æ·±å»ã§ãããšè¿°ã¹ãŠãäžççãªã¯ã¯ãã³æ¥çš®ã®æšé²ãšå
¬è¡è¡ç察çã®éèŠæ§ãæ¹ããŠèšŽããŸããã
[å¿åãã]
?
Good!
?
Bad
ãæ°åã³ããã京倧ç
é¢ãã³ããæ£è
ã«äžçåã®çäœèºç§»æ€æè¡ãå®æœ
京éœå€§ç
é¢ïŒäº¬éœåžå·Šäº¬åºïŒã¯ïŒæ¥ãæ°åã³ãããŠã€ã«ã¹ææåŸã«äž¡èºãã»ãŒæ©èœããªããªããïŒïŒ¯ïŒãšã¯ã¢ãäœå€åŒèå人工èºïŒã§ã®æ²»çãç¶ããŠãã女æ§æ£è
ã«ã€ããŠã芪æïŒäººã®èºã®äžéšãäž¡èºãšããŠç§»æ€ããçäœèºç§»æ€æè¡ãå®æœãããšçºè¡šããã
ãåç
é¢ã«ãããšãã³ããææåŸã®èºé害ã«å¯Ÿããè³æ»èºç§»æ€ã¯äžåœã欧米ã§å®æœãããŠããããçäœèºç§»æ€ã¯äžçã§åããŠã
ã移æ€ãåããã®ã¯ãé¢è¥¿åšäœã®å¥³æ§æ£è
ã§ãæšå¹Žæ«ã«ææãèºçã®åŸéºçã§äž¡èºã硬ãå°ãããªããã»ãšãã©æ©èœããªããªã£ããïŒã«æ以äžã«ããã£ãŠïŒ¥ïŒ£ïŒïŒ¯ã§ã®æ²»çãç¶ããŠããã
ãä»æïŒæ¥ãïŒïŒ¯ãè£
çãããŸãŸäº¬å€§ç
é¢ã«æ¬éãïŒæ¥ã«çŽïŒïŒæéã«åã¶ç§»æ€æè¡ãåãã女æ§ã®æ¯åã®å³èºã®äžéšãå³èºãšããŠã倫ã®å·Šèºã®äžéšãå·ŠèºãšããŠç§»æ€ããã女æ§ã¯çŸåšãéäžæ²»ç宀ã«å
¥ã£ãŠããããé 調ã«ããã°ïŒã«æã§éé¢ã§ããïŒã«æã§ç€ŸäŒåŸ©åž°ã§ããèŠéããèåšãæäŸããïŒäººã¯é 調ã«å埩ããŠãããšããã
ç£çµãã¥ãŒã¹ 2021.4.8 11:45
ttps://www.sankei.com/smp/life/news/210408/lif2104080010-s1.html
[å¿åãã]
?
Good!
?
Bad